ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000422.1|Saframycin_1 # 3 # 185 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.765	BGC0000422.1|Saframycin_1 	3	185	+	Loose	650	22.3274	MexA	57.89	3000377	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATCCGGCTGGAGACCCTCGACGCCCTGCTCCTGATCGCCGAGGGCCGCCCGCAGGAGGGCCGCGCCCTCCTCAAGCGCCTGGGCGAGGAGGCCCACCGCACCTCCAGCCACGACCTGGCCGCCGAAACCTGGCGCCTCCTGGCCGAGACCCTGGAGAACGCCGGGCCCCCCGGCCCGGCCTGA	IRLETLDALLLIAEGRPQEGRALLKRLGEEAHRTSSHDLAAETWRLLAETLENAGPPGPA	MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAFRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRYKLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTNGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPLEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRDLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTVPAKNVASAQKADAAPAKTDSKG	15.67	gnl|BL_ORD_ID|438|hsp_num:0	440			186	243	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000422.1|Saframycin_2 # 245 # 1069 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.710	BGC0000422.1|Saframycin_2 	245	1069	-	Loose	1250	25.7942	mecC	37.04	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGACCGTGCGCAAGAGCGTGGCCGCGCTGACCCCCGACGAGAAGCGGGCCTTCGTCAACGCGGTGCTGGAGCTGAAGCGGACCGGCGTCTACGACCGGTACGTCAACGCCCACAACTACTACCTGATGAGCGACTCGGACTTCGGGCCCCGGATCGGGCACCGCACGCCGTCGTTCCTGCCCTGGCACCGGCGGTTCCTGCTGGACTTCGAGGCCTCGCTCCAGCGGGTGGACCGCAACGTGGCGCTGCCGTACTGGGACTGGACCGTCGACCGGGCGGCCAACTCGCCGCTGTGGGCCTCCGACTTCATGGGCGGCAGCAGGCGGGGCCGGGACGGCCAGGTGCTCGACGGCCCGTTCGCCGCAGGGGGCGGCAAGTGGCCGGTGACGGTGGGCGTGGACCGCCGCGACTACCTGCGGCGCGTCCTGGGGTCGGGGGTGCCGCAGCTGCCGACGCGGGCCGAGGTGGACGCGGTGCTCGCGATGCCGGTGTACGACACCGCGCCCTGGAACAGCTCGTCGAGCGGGTTCCGCAACCACCTGGAGGGCTGGCGCGGGACCAACCTGCACAACCGGGTGCACGTGTGGGTGGGCGGGCACATGGCCACCGCGGCCTCCCCCAACGACCCGGTGTTCTGGCTGCACCACGCCTTCATCGACAAGCTGTGGGCGGACTGGCAGGCCCGCAACCCCAAGGCCGGCTACCTGCCTTCCGGACGGACGCAGAACGTGATCGACCTGCGGGGCGTGCTGCCGCCGTGGAACAACGTGACTCCGGCCGACATGCTGGACCACCGCCGGTTCTACACCTTCGACAAGCCGTGA	MTVRKSVAALTPDEKRAFVNAVLELKRTGVYDRYVNAHNYYLMSDSDFGPRIGHRTPSFLPWHRRFLLDFEASLQRVDRNVALPYWDWTVDRAANSPLWASDFMGGSRRGRDGQVLDGPFAAGGGKWPVTVGVDRRDYLRRVLGSGVPQLPTRAEVDAVLAMPVYDTAPWNSSSSGFRNHLEGWRGTNLHNRVHVWVGGHMATAASPNDPVFWLHHAFIDKLWADWQARNPKAGYLPSGRTQNVIDLRGVLPPWNNVTPADMLDHRRFYTFDKP	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	41.20	gnl|BL_ORD_ID|742|hsp_num:0	810			1023	1104	methicillin
BGC0000422.1|Saframycin_3 # 1066 # 1488 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000422.1|Saframycin_3 	1066	1488	-	Loose	560	29.261	OXA-302	26.51	3001757	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGAAGATCACTCGCCGACAGGCTCTGGGGATCGGTACCGGGGCGTCCATCGCCCTGGGCCTGAGCGCCTGCTCGTCCTCGTCGGCCCCGGCCCCGGCGGCCTCCGGTGCCTCCGGGAGCCCCGGTGCTTCCGGGGCACCCCTGTCCATACCCACCGGCGGCATCGACGAGGTGTACGAGGGGCGCCGCATCCAGATCACGCTGGGTGCCGCGGGGCACCACGGCATGCCGATGCCCAACATCAAGATCGACGGCAAAGAGCTGCACCTGATGGGCAACGCGGACGGCAGCTGGGTCACCGTCGTCAACCACTACGAGAGCTTCCCGGACCCGGTCGCGGCCGCCCGCGCCGCCATCCGCGACCTCCAGGGCGCCGAACTCGCGCCGTTCACGCTCCCGAAGGAGGCTCCGCAGCTGTGA	MKKITRRQALGIGTGASIALGLSACSSSSAPAPAASGASGSPGASGAPLSIPTGGIDEVYEGRRIQITLGAAGHHGMPMPNIKIDGKELHLMGNADGSWVTVVNHYESFPDPVAAARAAIRDLQGAELAPFTLPKEAPQL	MMMSKKLKCLALLTPCILILQLTACQSVSQQKQQLSTQTNEQQQISSLFQSAQTKGVLVIYDGKKIQSYGNDLNRAEQRYIPASTFKILNALIGIQYHKTTPNEVFKWDGKKRTFSSWEKDLSLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLQITPVEEVRFVYALAKQKLPFDQSTQQQVKGMLLADERQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKTIAFSLNMQMSQPEHANARKVIVYQALQELGLLAN	50.00	gnl|BL_ORD_ID|2392|hsp_num:0	3464			15	264	cloxacillin; oxacillin; cefalotin
BGC0000422.1|Saframycin_7 # 4880 # 5161 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.777	BGC0000422.1|Saframycin_7 	4880	5161	+	Loose	1100	30.4166	oleB	50.0	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCGGCCGAAGCGGTCGTCCGGGAAGGAGCCCACGAGCTCCCGGACCGCCTGGTGACCCACCGCCCCGACCAGCGCCGTGAGGTCGCCGCGCAGGCTCCCCGTGTCGGCCGGCTCGAACCGGAAGCCGACGGCGACCTGCACCGCACGGTCCGCCACGGCAGCGGCTACGCCGGCTACCTCGCCGGCAGCGCCGCACCCGGGCCCACACCGCCTGGCGCGAGGAGACGGACCGGCTGCGGGAGTCCGCCGGCGTCACCGCCCGCAAGGGCCGGACCGTGA	MAAEAVVREGAHELPDRLVTHRPDQRREVAAQAPRVGRLEPEADGDLHRTVRHGSGYAGYLAGSAAPGPTPPGARRRTGCGSPPASPPARAGP	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	16.34	gnl|BL_ORD_ID|1272|hsp_num:0	1388			756	852	oleandomycin
BGC0000422.1|Saframycin_8 # 5283 # 5924 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.724	BGC0000422.1|Saframycin_8 	5283	5924	-	Loose	550	37.7354	RlmA(II)	23.53	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGTGGGTGGGTATCGGGATGGGGCCAGGGCGGGTTACGACGGGGTCGTCGAGCTGTACGCCTCGATGTTCGCCGATCGGCTGGAGACGCGGCCGTTCGCGCGGGCCATGGTGGGGGTCTTCGCCGGGATGGTGCGGGAGGCGGGGAACCTGCGGGTGGCCGATGTCGGGTGTGGGCCCGGGCATCTGACCGGGTTGCTGGGCGAGTTGGGGGTGGAGGCCTTCGGGGTCGATCTCTCGCCGGGGATGGTGGAGCACGCCCGGCGGGCGCACCCGGGGCTGCGGTTCGTCGAGGGGCGGATGGAGGCCCTGCCGGTGGAGGACGGGGCGCTCGGCGGGGTGCTGGCCCACTACTCGATGATCCACACCCCGCCCGGGGAGCTGCCCGGGCTGCTCGCCGAGCAGGTGCGGGTGCTGGCGCCGGGGGGTTTGCTGCTCGTTTCGTTCTACGTGGACGAGGGGGCGGCGGAGCCGGTGCGTTACGAGCACAAGGTGGCGCCCGCTTACAGCTGGCCGGTGGAGCGGTTCGTGGAGGTGCTGGCTGGGGCGGGGTTCGAGGTGGTGGCCCGGATGGTTCACGGGCCGGTTTCCGAGCGGGGGTTCCTGGAGGGCCATCTGCTGGCCCGGGTCGTCGTCAGGTGA	MVGGYRDGARAGYDGVVELYASMFADRLETRPFARAMVGVFAGMVREAGNLRVADVGCGPGHLTGLLGELGVEAFGVDLSPGMVEHARRAHPGLRFVEGRMEALPVEDGALGGVLAHYSMIHTPPGELPGLLAEQVRVLAPGGLLLVSFYVDEGAAEPVRYEHKVAPAYSWPVERFVEVLAGAGFEVVARMVHGPVSERGFLEGHLLARVVVR	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	75.53	gnl|BL_ORD_ID|2052|hsp_num:0	2274			231	561	tylosin; mycinamicin
BGC0000422.1|Saframycin_9 # 6034 # 6405 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.704	BGC0000422.1|Saframycin_9 	6034	6405	+	Loose	200	26.9498	FosA3	30.17	3002872	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGCCGCCCCTCCACATGAGACTGTGCGCGATAACCCTCGACTGCCCCGATCCGCAGGCCCTGGCCGCGTTCTACCAGCAGGCGACCGGCCTCGAACCCCACCCCGCGTCCGACGCCGACTTCGCCGGCCTCAACGGTGAGCACGGACTCTTCCTCGGCTTCCAGCGGGTCGAAAACCACCGCGCACCCACCTGGCCCGACCAGACCGTCCCCCAGCAGTCCCATCTCGACTTCGCGGTAGCCGACCTGGACGCAGCCGAGACCCGGCTCCTCGCACTGGGCGCCACCAAGCCCGACCACCAGCCGCACCCCACCAGGTGGAGGGTCCTCACGGACCCGGCCGGCCACCCCTTCTGCCTGGTCAGAGCCTGA	MPPLHMRLCAITLDCPDPQALAAFYQQATGLEPHPASDADFAGLNGEHGLFLGFQRVENHRAPTWPDQTVPQQSHLDFAVADLDAAETRLLALGATKPDHQPHPTRWRVLTDPAGHPFCLVRA	MLQGLNHLTLAVSDLASSLAFYQQLPGMRLHASWDSGAYLSCGALWLCLSLDEQRRKTPPQESDYTHYAFSVAEEEFAGVVALLAQAGAEVWKDNRSEGASYYFLDPDGHKLELHVGNLAQRLAACRERPYKGMVFFD	89.13	gnl|BL_ORD_ID|771|hsp_num:0	834			21	342	fosfomycin
BGC0000422.1|Saframycin_10 # 6484 # 7125 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000422.1|Saframycin_10 	6484	7125	+	Loose	250	25.7942	FosM1	42.42	3007097	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGGTCATGGCAAACACCGCTTCCCCCGCAGCCCCCACCGCCCTCGCCTCCGTCACCCTCGAGGTGGCCGACACCGAGGCCGCCCGCCGCTTCTACACCGCCTTCGGCGTGGACGCGTACGTCACCCTGCGGGCGTCCGACACGCCCACCACCGGCTTCCGCGGCTTCACCCTCGGCATCACGGTCTCCGGCCCCGCCACCGTCGACGGCTTCTTCGCCGCGGCGGTCGACGCCGGCGCCACCGTCCTCAAGCCCACCGCCAAGTCGCTGTGGGGCTACAGCGGAGTGGTCCAGGCCCCGGACGGCACGATCTGGAAGATCGCGACCGGAGCGAAGAAGGACACCGGCCCCGACACCCGCCGGATCGACGAGATCGTCCTGCTGCTCGGCGTCGAGGCCGTGAAGGCCACCAGGCAGTTCTACGTCGAGCAGGGCCTGACCGTCGCCAAGAGCTTCGGCGGCAAGTACACCGAGTTCGCCCCCGGCACCGCCGGCCCCGTGAAGCTGGCCCTGTACAAGCGCCGCGCCCTGGCCAAGGACCTCGGCGTCCCCGTCGAAGGCACGGGCTCCCACCGCGTCGTCCTCGGCACCACCGCCACCGCCTTCACCGACCCGGACGGCTTCACCTGGGAAGCGGCCTGA	MVMANTASPAAPTALASVTLEVADTEAARRFYTAFGVDAYVTLRASDTPTTGFRGFTLGITVSGPATVDGFFAAAVDAGATVLKPTAKSLWGYSGVVQAPDGTIWKIATGAKKDTGPDTRRIDEIVLLLGVEAVKATRQFYVEQGLTVAKSFGGKYTEFAPGTAGPVKLALYKRRALAKDLGVPVEGTGSHRVVLGTTATAFTDPDGFTWEAA	MNIKGINHFLFSVSNLEESIKFYQSVFDAKLLVKGTSTAYFDLNGIWLALNEEIDIPRNEINQSYTHIAFSIEEGDFEKVYEKLKQLHVHILTGRERDVKDKKSIYFTDPDGHKFEFHTGTLQDRLAYYQQEKKHMEFFN	152.14	gnl|BL_ORD_ID|4777|hsp_num:0	5772			252	348	fosfomycin
BGC0000422.1|Saframycin_11 # 7185 # 7598 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.684	BGC0000422.1|Saframycin_11 	7185	7598	+	Loose	100	25.409	FosH	43.48	3007369	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAAGGCACACGTCAGCTCGATCCTCCTCGGCGTCCGTGACATGGACCGCGCCAAGCGCTTCTACACCGAGGGCCTCGGCTGGAAGGTCCAGAACGACTTCGGCATCTCGGTGTTCTTCGAATCCGACGGCGCCTCGCCCGTCGGCTTCTACAGCCGCGAAGGCCTGGCCGGCCAGGTGGGCACGGACCAGGAGGGCAGCGGCTTCAGCGGTCTGGTCCTGACCTACGTCGTCCGCAGCGAGACCCGGGTCGACGAGATCATGGCGGAGGCGGCGAAGGCCGGCGCCAAGGTCCTCAAGCCCGCCGACGCCCTCCCCTGGGGCGGTTACGGCGGTACCTTCGCCGACCCCGAGGGCTACATCTGGAGCCTCGGCTACAGCGCCCAGGGAACCGACCAGCCCTACGCGGAATAG	MKAHVSSILLGVRDMDRAKRFYTEGLGWKVQNDFGISVFFESDGASPVGFYSREGLAGQVGTDQEGSGFSGLVLTYVVRSETRVDEIMAEAAKAGAKVLKPADALPWGGYGGTFADPEGYIWSLGYSAQGTDQPYAE	MGILGISHLTFVVRDVERTARLVCEGLGAEEVYDSKAKNFSLSREKFFLLGGVWLAFMEGVPSERSYRHVAFEVTEEEIARYEASLRNLGVEVREPRPRVAGEGLSLYFYDYDNNLFELHAGTLAQRLERYTQ	103.01	gnl|BL_ORD_ID|4904|hsp_num:0	5897			15	84	fosfomycin
BGC0000422.1|Saframycin_12 # 7628 # 8062 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.726	BGC0000422.1|Saframycin_12 	7628	8062	+	Loose	500	26.1794	rmtD2	41.67	3004677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAAATTCCGCACCCACGTCGAGCCCCCCGAGCCCATGCGGGGCCTGGAAGTCCCGCCCGAGGTGGTGGCCGCGCTCGGCGGGGGCGCGCGGCCACCGGTGACGATCACTCTGGGCGGCCACTCCTGGAAGAGCCGGATCGCCCTCCTCCGCGGCCGCCACCTGCTCGGCCTCAGCAACGCCAACCGCCAGGCCGCCGGCGTCGCCGTCGGCGACGAGGTCGAGGTCGAGCTGGAACTCGACACCGAACCCCGCGTCGTCGTCGAGCCTGCGGACTTCGCCCAGGCCCTGGACGCCGACCCGGCAGCCCGCGCCGCCTACGACAACCTGGCGTACAGCCGCAAGCGCGAGCACGTACGCGCCATCGAGAGCGCGAAGAAGCCCGAAACCCGCCGAAGCCGCATCGAAAAGGCCCTCACCACCCTGCGGGGCTGA	MKFRTHVEPPEPMRGLEVPPEVVAALGGGARPPVTITLGGHSWKSRIALLRGRHLLGLSNANRQAAGVAVGDEVEVELELDTEPRVVVEPADFAQALDADPAARAAYDNLAYSRKREHVRAIESAKKPETRRSRIEKALTTLRG	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREYKRAMELAATRDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYLAHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALMFKVLPLLERQRTGAAMEALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	58.30	gnl|BL_ORD_ID|2225|hsp_num:0	3376			57	201	amikacin; netilmicin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000422.1|Saframycin_13 # 8199 # 8816 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.710	BGC0000422.1|Saframycin_13 	8199	8816	+	Loose	400	40.817	tetR	29.17	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTGGGACGTCCCCGAGGGGTCGACGACGTGGACATCCTGCGTGCGGCGGCAGACGTGATCGGCCGGGTGGGGCCCGCGGGACTCACGCTCGCCGCCGTGGCCGGCGAGGTGGGCCTCGTACCGGGCACCCTCCTGCAGCGGTTCGGCTCCAAGCGCGGGCTCATGCTGGCCATCGCCCGGGAGTCGGCCAAGGAGGCCGAATCCGTGTACGAGAGCATGCGTGACGAGCACGCCACTGCCCTCATGGCCGTGACGGACCTGGCCGTGACCTCAATGGGCGTCATGACCAAGCCGGAGGTCTACGCGAACCATCTGGCCTTCCTGTGCATCGACCTCACGGACCCGGAGTTCCACGCGCACGCCCTCACCATCCACCAGGCCCAGCGGCGGGTATACGAGGCCCTGCTCACCGAGGCGGTGGACAACGGGGAGCTGTTGGCCGGCACCAATGTCGCGGCGCTGGCCACCACCCTCCAGGCTGTCGTCGCGGGCGCGGGCCTCACCTGGGCCCTGGACCGCGAGGGCACCCTGCCCCACCGGCTCGAACGCGAGGTCATCACGGCCCTAGCCCCCCACATCACGCCGCAGGGTGACTCCGCAGGGGAGGGATCGTGA	VVGRPRGVDDVDILRAAADVIGRVGPAGLTLAAVAGEVGLVPGTLLQRFGSKRGLMLAIARESAKEAESVYESMRDEHATALMAVTDLAVTSMGVMTKPEVYANHLAFLCIDLTDPEFHAHALTIHQAQRRVYEALLTEAVDNGELLAGTNVAALATTLQAVVAGAGLTWALDREGTLPHRLEREVITALAPHITPQGDSAGEGS	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	98.56	gnl|BL_ORD_ID|442|hsp_num:0	276			12	366	tetracycline
BGC0000422.1|Saframycin_14 # 8813 # 9727 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.722	BGC0000422.1|Saframycin_14 	8813	9727	+	Loose	475	25.409	cphA3	25.84	3003093	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	GTGACCGACGGCGTCCGCACACTGGCCGGCAAGGTCGCCCTCGTCGCCGGAGGCACGCGCGGAGGCGGGCGGGGCATCGCCGTCGAACTCGGTGCCGCCGGCGCGACGGTGTACGTCAGCGGCCGCAGCAGCTCGGCCAACGGAAGCTCCGACATGGGCCGCCCGGAGACCATCGAGGAGACGGCGCGGGCGGTCACCGCCGCCGGAGGCGTGGGCATCCCGGTGCGCACCGACCACAGCAGCCCCGAAGAGGTCCGCGCGCTGGTCGACCGGATCGACGCCGAGCAGCAGGGGCGCCTGGACGTCCTGGTCAACTGCGTCTGGGGCGGGGACCGGCTGACCGACTGGAACCGTCCGCTGTGGCAGCAGGACCTCGACAAGGGGTTGAGGCTGCTGCGCCAGGCCGTCGAGACTCACGTGATCACCAGCCGGTACGCCGTGCGGCTGATGGCCGCCCGCCGCAGCGGCCTCGTCGTGGAGGTCACCGACGGCAACACCGCCCGCTACCGCGGATCCTTCTTCTACGACGTGGCGAAGTCCACGGTGATCCGCCTGGCCTTCGCACAGGCCGCCGACCTGAAGGAACACGGCGTCGCGGCCGTCGCCATCACGCCCGGCTTCCTGCGCTCGGAGGCCATGCTGGAGCACTTCGGCGTCACCGAGGACAACTGGCGCGACGGCGTGGCCAGGGACCCGGACTTCGCGCATTCCGAGACCCCGGCATACCTGGGCAGGGCGGTGGCCGCCCTGGCGGCCGATCCCGACATCATGGCGAAGACCGGGCGGGCGCTGGCCACCTGGGGCCTGTACAAGGAATACGGGTTCACCGACATCGACGGCAGCCAGCCGGACTTCGCCGCCCACTGGGCCAGGACCCTGGAGCCGCGGCTCGGACCGCTGGGTACCCCCTTGTAG	MTDGVRTLAGKVALVAGGTRGGGRGIAVELGAAGATVYVSGRSSSANGSSDMGRPETIEETARAVTAAGGVGIPVRTDHSSPEEVRALVDRIDAEQQGRLDVLVNCVWGGDRLTDWNRPLWQQDLDKGLRLLRQAVETHVITSRYAVRLMAARRSGLVVEVTDGNTARYRGSFFYDVAKSTVIRLAFAQAADLKEHGVAAVAITPGFLRSEAMLEHFGVTEDNWRDGVARDPDFAHSETPAYLGRAVAALAADPDIMAKTGRALATWGLYKEYGFTDIDGSQPDFAAHWARTLEPRLGPLGTPL	MMKGWIKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEELIKAVPQS	119.69	gnl|BL_ORD_ID|1649|hsp_num:0	1687			24	258	
BGC0000422.1|Saframycin_15 # 9636 # 10610 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.669	BGC0000422.1|Saframycin_15 	9636	10610	-	Loose	620	26.1794	ROB-13	50.0	3005072	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGGTTCTCCCCCTGGTGGACTCTGCGCGGGTACGGGGACGCGCGCGGTCGGATCCACATGCGCGTCGCCAGCGATTGTCGACGCGCAGCGGTCGATGCCGGGTCGAATCCTTCGAGTCCCTGAAAGACGAATCCGCGGGTGTCCCGCCGGGGAGGCCCTGGTGCGGCCCGCTACGAGGCGGCGTCCGCGGACTCCATGACGTAGCCGCGCCCCCACACCGTACGCAGGGCGAGGTCGAGGGGTTTCACCCGGCGGCGGATCCGCATGATGTGCAAGTCCAGGGCATTTCGGCTGGGCTGCGAAGTCCGGGACAGCGCTTCCAGCAGGACTTCCCGCGGGACGACATGGGAAAACGATTCCGCGAGGCGATTCACCAAATCCGTCTCGGTCGGGGAAAGCACCACGGACATCCTGCGATAGCGCAGGACGCCGTTCGGATCCACCGTCGGCAGGAAGTCCGCGCTGCCCTTCACGCGCAGCGCGTCGATCCGCGCGCGAAGGTCGCTCCTACTGACCGGGGTACGGACCCAGTCCTCCCGGACGTCCGTACACACCGGGGCTTCGACCCCTGCTTCCAGCACCAGGAGCCGCATGACCCCCTGGTCCCTGCATGCCGCCCGACGGGCTGCGTCCACCGGCCACCTGATCAATTCCACTTTCGATTCAATTGCGTTAAGCACCGAAGCAGACCTCCCTGTGCCATGGGCACGGTGGATTCCGGATTGGCACGTACCTGTGTGCACAGTAGCCAAGGGAGATCCCGTCCTGGCAGCCACCTCCAGTTGGTCTCAAGCGTCTTTCCGCGCAGTGGTGGAGAACCCCTGGGGCGCCGCGGACAACGGCTGTGCGCAGGTATTAGCGTGGCTCTTTCCGGGAAGCGCCCTACAAGGGGGTACCCAGCGGTCCGAGCCGCGGCTCCAGGGTCCTGGCCCAGTGGGCGGCGAAGTCCGGCTGGCTGCCGTCGATGTCGGTGA	MVLPLVDSARVRGRARSDPHARRQRLSTRSGRCRVESFESLKDESAGVPPGRPWCGPLRGGVRGLHDVAAPPHRTQGEVEGFHPAADPHDVQVQGISAGLRSPGQRFQQDFPRDDMGKRFREAIHQIRLGRGKHHGHPAIAQDAVRIHRRQEVRAALHAQRVDPRAKVAPTDRGTDPVLPDVRTHRGFDPCFQHQEPHDPLVPACRPTGCVHRPPDQFHFRFNCVKHRSRPPCAMGTVDSGLARTCVHSSQGRSRPGSHLQLVSSVFPRSGGEPLGRRGQRLCAGISVALSGKRPTRGYPAVRAAAPGSWPSGRRSPAGCRRCR	MFNKLKIGTLLLLTLTACSLNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	106.23	gnl|BL_ORD_ID|4806|hsp_num:0	3808			690	756	
BGC0000422.1|Saframycin_17 # 12181 # 13620 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.699	BGC0000422.1|Saframycin_17 	12181	13620	+	Loose	1000	182.185	efpA	33.4	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTCGCCGAGCAGGGCGCGCCGAGCGCCAAGGCGGGCAAGACCCTCCTCACCCTGTTGTGCCTGGCCCAGTTCATGCTGATCCTGGACGTCGCCGTGGTCGCGGTCGCCGTCCCGTCGATGCAGTCGCAGCTGAACATCTCCGCGGCCAACATCCAATGGGTCAGTACCGCGTACGGCCTGGCGTTCGGTGGCTTCCTGGTCGCTTCCGGCCGAGCGGCCGACCTGTTCGGCCCCAAGCGGATCCTGCTCATCGGGCTCTCGCTGTTCACACTCGCCTCGGGGCTGTGCGGCATCGCGCCCAACGAGCTGACGCTGTTCGTGGCCCGCGCGGTGCAGGGCTTCGGCGCCGCTCTGGTGTCGCCGGCGGCCCTGTCGCTGGTCACGACCAGCTTCGGGGAGGGCGAGGAGCGCAACAAGGCGCTCGGGCTGTGGGGAGCGGTCTCGTCCGGCGGTGCCATCGCCGGCCAGCTGCTCGGCGGCGTGCTCGCGGACCTCGCGGGCTGGCGGTCCATCTTCCTCATCAACGTCCCGCTCGGCCTGATCGTGATCGTGGCCGTCGCCCGCATGGTCCGCAAGGACCGGTCGAACGACACCGGCCGCATCGACATGGCGGGCGCCGGCCTGCTCACCGCCGGAGTGGTGCTCCTCGTGACGGCCGTGTCGCAGGCCGCCGAGCGCGGTGTGGGCCTGCCCGTCCTGATCAGCGGTGTGCTCGGAGCGGTCCTGCTGGTCTTCTTCGTGGTGCACGAAGGCCGCGTCCAGAACCCCGTCCTGCGCCTGTCGATGTTCCGCAACCCCAATGTCCGTTACGGCAACATGATCTGCATGCTGACGGCCGGAGGCGCGACGGTCTCGGTGTTCCTCGGCACTCTCTACATGCAGCAGGTCATCGGGATGAGCCCGATGATGGCAGGCCTGGGCTTCGCTCCGGTCACCCTGCTGATCCTGGGCGTGTCGATGCGCATGGGCCCGCTGGTGCAGAAGTTCGGCGTGAAGAACCTGCTGCTGGCCTCGGCCGCGCTGTTCGCGGTGGGTTCGCTGCTGCTGAGCTTCGTCACGGTCGACGGCTCGTACTGGGTGCAGGTGTTCCCCGGCCTCGCCATCGGAGGCGTCGGCGCGGCCCTGAGCTTCGCCCCCTCGATGATCCTCTGCACCACCGGGGTCCCCGACGAGGAGCAGGGCCTGGCTTCGGGGCTGCTCGGCACCTCGCAGCAGATCGGTGCGGCGCTCTTCCTGGCCATCCTGAGCGGGGTCACCGCCGCGGTGGCCGCCTCGTCCGGCGGCGACACCCCCGAGGCGCTGACCGAGGGCTTCCAGGCGGGGTTCCTGTGGTCGCTGGCGATCCCGGCACTGATCGTCCTGTGCCTCCTGGCCCTGCCCAGGAAGAAGGACGAACCGCAGGTGGAGCCGGCGGCGGAGCAGACCGAAACGGTCTGA	MVAEQGAPSAKAGKTLLTLLCLAQFMLILDVAVVAVAVPSMQSQLNISAANIQWVSTAYGLAFGGFLVASGRAADLFGPKRILLIGLSLFTLASGLCGIAPNELTLFVARAVQGFGAALVSPAALSLVTTSFGEGEERNKALGLWGAVSSGGAIAGQLLGGVLADLAGWRSIFLINVPLGLIVIVAVARMVRKDRSNDTGRIDMAGAGLLTAGVVLLVTAVSQAAERGVGLPVLISGVLGAVLLVFFVVHEGRVQNPVLRLSMFRNPNVRYGNMICMLTAGGATVSVFLGTLYMQQVIGMSPMMAGLGFAPVTLLILGVSMRMGPLVQKFGVKNLLLASAALFAVGSLLLSFVTVDGSYWVQVFPGLAIGGVGAALSFAPSMILCTTGVPDEEQGLASGLLGTSQQIGAALFLAILSGVTAAVAASSGGDTPEALTEGFQAGFLWSLAIPALIVLCLLALPRKKDEPQVEPAAEQTETV	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	90.38	gnl|BL_ORD_ID|2188|hsp_num:0	2427			183	1575	rifampin; isoniazid
BGC0000422.1|Saframycin_18 # 13732 # 16191 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.728	BGC0000422.1|Saframycin_18 	13732	16191	-	Loose	1280	51.9878	macB	36.46	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCCGGAAAGCCCCTTCCCCCACAGCAGCACGGAATGGATCAGGGTGGTACGCGCCCGGACGCACAACCTGAAGGACGTCACCGTGGACATTCCACGGGGCGGGATCGTCGCCTTCACGGGGGTCAGCGGGAGCGGCAAGACCTCACTGGCGATCGACACGGTCCACGCGGAAGCCCAACTGCGCTACCTGGAGGGCCTTTCGCCCTTCGTCCGCCAGTACATCACCCCCAAGGACCGCCCGCAGGTGGACCGCATCGACGGCCTCGGCGCCACCCTCGCCGTTGACCAGCGCCGCCTCAACCGCCATTCGCGGTCCACGGTCGCCACGATGACCGGCGTCGACGCCTACCTCGGGCTGCTCTACTCCCGGCTGCCCGCGGTGGCCGGGGAGGGACCGGAGCTGTCCAGCGGGCACTTCAGCCGCTACAGCCCGGAGGGCGGCTGCCCCGTCTGCCACGGCGCCGGCGGCACTCCCCGTGCGGACGCCGACCTGATCATCACCCACCCCGGCCTCCCCCTCCAGGAGGGCGGATCGCCGTGGTTCGACAAACTGCGCTCGCCGGAGCAGGTGGCGGTGCCCTTCCTGGCGGAGCGCCACGGCGCGGACCTCTCCCTGCCGTGGCGGGAGCTGCCCCAGTCCTTCCGCGACGCCTTGCTGTACGGAACGGGCACGGAAACCGTGAGCGTCAGCGTGCAGGTCCCCAACAAGAACTCCGACGCCGAGGTCCTCTACCAGCTCAACCAGCCGCTGCGCGGTGCGCTGGCCGAGGTCGAGCGGCTGTTCGCCGCGGCCGGTACCGAGAACGCCAAGCAGCGCTACCTGCCGTACATGCGCCAGATCCCCTGCGCGCAGTGCGGTGGCAGCGGCTACGGCGAGGCCGCCCGTACGGTGGCCCTGGCGGGCGTCACGTACCAGCAGCTGTCCGCCCTGCGGGTGCACGAGGTGCAGAAGTGGGCCGCCGAGCTCGGCGGCGTCCTCAGCGGCGTCCAGCGCGAGATCGGCGAGGCGCTGCTGCCCGAGGTGACGAACCGGCTGCGGCTGCTCGACCGGTTGGGCCTGGCCCATCTCGAACTCGGCCGCACGGCCCCGACCCTCTCCGGCGGGGAGCTCCAGCGCGCCCGTACGGCCGCTCAGCTCAGCACCTCGCTGACGGGCATCGTCTTCGTGCTCGACGAGCTGGGGTCCGGACTGCATCCCGCGGACAAGCAGAAGCTGCGCGACATCCTGGAAGACCTGCGGGACTCGGGCAACACCGTTCTGCTGGTCGAGCACGACCCGGACGTCGTGGCCCAGGCGGACTGGGTCATCGACCTCGGCCCCGGCGCCGGCAGCGGTGGCGGCCGGGTGATGTTCTCCGGTCCCCCGCAGGAGCTCGCGGCCCATCCCGACTCGGTGACCGGCCGCTACCTGGACCGCAGCCGGCCGCGCATCAACCGCGCCCGGTCCGGCGGCGGCAGCGGCAGGTGGCTGACGTTCAAGGACGTCCGGGCGCACACCGTACGGGTGGACGAGCTCCGCGTCCCGCTGAACACCCTGACCTGTTTCACCGGCGTCAGCGGAAGCGGCAAGAGCAGCCTCCTGGGCCATGCCGTCGCCCCCGCGCTCACCGCCGCCCTCGCCGGTTCGGGCCATCCTGCGGTGGGGGCGGTCACCGGCATCGAGTCCGTGGCGTGGGTGGACTGCGTCGACCAGAGTCCGATCGGCCGCACCCCGCGGTCCAATCCGGCCACGTACACCAAGGCGTTCGACGCGGTCCGCAAGCTGTACGCGGCCACGGACCGCGCCCGCGCGCTGGGCCTGGGCGCCTCCGCCTTCTCCTTCAACGCGGCCGCGGGACGCTGCGAGGCGTGCACGGGCTACGGCCAGAAGCTGGTGGACATGCACTTCCTGCCCGACGTGTGGGCGACCTGTGACGTGTGCGCCGGACGCAGGTTCACGCCCGAGGTCCTGTCCGTCACCTACCAGGGCCTGGCCATCGACCAGGTGCTCGGGCTGACCGTCGACGAGGCGGCGGAGTTCTTCCGCGAACCGCGCACCCTGACGGCCATCCTGCACGCCCTCCAGCAGGTCGGCCTCGGCTACCTCCAGCTCGGCCAGAGCGCCACCGACCTGTCCGGGGGCGAGGCGCAGCGCCTCAAGCTGGCGGAGGCGATACGCCGGGGCGCCGTGGGTGGCCGCGGCGGCGTGGTCCTGCTGGACGAGCCGCTGACCGGGCTGCACCCGGCCGATGTGCAGCGGATGGTGAGCGCCTTCGACGCCCTGCTGGCCGCGGGCCACACCCTGCTGGTCGCCGAGCACGACCTGCACCTGGCGGACAGCGCCGACTGGCTGGTCGACATGGGGCCCGGAGCCGGCGAGCACGGCGGGCGCGTCGTCGCCGAGGGCACCCCCGAGCAGATCCGGGCGGCCGACAGCGCCACCGCCGGCCACCTGCGCCGGCTCGTCCCACGCGGCTGA	MPESPFPHSSTEWIRVVRARTHNLKDVTVDIPRGGIVAFTGVSGSGKTSLAIDTVHAEAQLRYLEGLSPFVRQYITPKDRPQVDRIDGLGATLAVDQRRLNRHSRSTVATMTGVDAYLGLLYSRLPAVAGEGPELSSGHFSRYSPEGGCPVCHGAGGTPRADADLIITHPGLPLQEGGSPWFDKLRSPEQVAVPFLAERHGADLSLPWRELPQSFRDALLYGTGTETVSVSVQVPNKNSDAEVLYQLNQPLRGALAEVERLFAAAGTENAKQRYLPYMRQIPCAQCGGSGYGEAARTVALAGVTYQQLSALRVHEVQKWAAELGGVLSGVQREIGEALLPEVTNRLRLLDRLGLAHLELGRTAPTLSGGELQRARTAAQLSTSLTGIVFVLDELGSGLHPADKQKLRDILEDLRDSGNTVLLVEHDPDVVAQADWVIDLGPGAGSGGGRVMFSGPPQELAAHPDSVTGRYLDRSRPRINRARSGGGSGRWLTFKDVRAHTVRVDELRVPLNTLTCFTGVSGSGKSSLLGHAVAPALTAALAGSGHPAVGAVTGIESVAWVDCVDQSPIGRTPRSNPATYTKAFDAVRKLYAATDRARALGLGASAFSFNAAAGRCEACTGYGQKLVDMHFLPDVWATCDVCAGRRFTPEVLSVTYQGLAIDQVLGLTVDEAAEFFREPRTLTAILHALQQVGLGYLQLGQSATDLSGGEAQRLKLAEAIRRGAVGGRGGVVLLDEPLTGLHPADVQRMVSAFDALLAAGHTLLVAEHDLHLADSADWLVDMGPGAGEHGGRVVAEGTPEQIRAADSATAGHLRRLVPRG	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	127.17	gnl|BL_ORD_ID|446|hsp_num:0	487			375	654	erythromycin
BGC0000422.1|Saframycin_19 # 16262 # 17827 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.739	BGC0000422.1|Saframycin_19 	16262	17827	-	Loose	550	295.819	Nocardia farcinica rox	41.57	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCCAGTTCCCCGTCCGTGCTGATCGTCGGCGCGGGACCGACCGGTCTCGCCCTCGCCGCCGAGCTCTCCGCGGCCGGGATCGCCTGCCGTGTACTCGACAAGCGGAGCACCCCCTCGCCCCACTCGCGGGCGTTCGGACTGCTTCCCCGCACCCTCGAACTGCTCGACATGCGCGGGCGCGCCGAGTCGTTCGTGGCGCAGGGCCTGCCCTGGGCGCATGCCGCGCTCGGCGACGGCAAGCGCTGGCTGGACTACCGCGACGTCGACAGCCCCTTCCCGTACATGCTCGTCATCCCGCAGAGCCGCACCGAGGAGCAGCTGACCTCCTGGGCCCTGGACTCGGGCGCCGTCATCGAGCGCGGGGCGACCGTGACCGGACTGCGCCAGCACGACGGCGGCGTCGAGGTGGAGGTGGAGGGGCCCGGGGGTCCGCGCACCGAGCACGCGGACTTCGTGGTGGGCTGCGACGGGGTGCACAGCACGGTGCGCGAACTCGCCGGTATCTCCTTCAGCGGATCCTCCTACGACAGTTCGCTGATCGTGGCCGACGTCCGGCTGGCCACCCCGCCGGACCCGCAGGTGTACGCCCGGACCGGCAAGCGCGGGATGGTCGTGCTCTTCCCGTTCGGCGACGGCACGTTCCGGCTCATCGCGCTCGACCACGCGCGGATGGGCGCGCCGGTGGACGAGCCCGTCACGGTCGACGAGCTGAGGGAGAGCTGCCGGGCGGTACTGGGCACCGACTTCGGGCTCCACGATCCGCTGTGGATGTCCCGCTTCCGCAGCGACCAGCGGCTCAGCGACCGCTACCGGCTCGGCCGGGTCCTGCTTGCGGGCGACGCCGCGCACACCCACATCCCGTCCGGCGGCCAGGGCCTGCAGACAGGGATCCAGGACGCCATGAACCTCGGGTGGAAGCTCGCCGCCCACCTGTCGGGGCGGGCACCGGCCCACCTCCTCGACACCTACCAGCGCGAGCGCCGCCCCATCGCTGCGGCGACCCTGCGCCGCACGGACCTGGTCTACAAGTTCGAGGTCTCCGACTCCGCGGGGGCCCGGCTGCTGCGCGGGCTCAGCACCCGCCTGATGGGGCTGGCGCCCGTACAGAACTCCGTCCTGGAGGAGCTGTCCGGGCTGAAGCTCCGCTACCGCCCCCTGGCCGGCACGACGGGACGGGTACCGCACCGGCTGGTCGGCCGACGGGTGCACGACACCGCGCTGCGCTCACGTGACGGCGTGGACAGCCGCCTCTACACCCACTTCCGCACGGGTGGTTTCGTGCTGCTCGACCAGTCCCACGGCGGCTTCTGCGCCGAGGTGGCCGAAGCGGGCTGGGCGGACCGCGTCACCGCGGTGCGGTCGGTGAGCGTAGGCCGCAAGAACCCGAAGGACCTGCCCGAGGCGTTGCTGGTACGCCCGGACGGCTACGTCGCCTGGGCGGGCCACGCCGGAGACACCCCCGGCCTGCGGGCCGCTCTGCACCACTGGTGCGGCGAGCCGGAGGCCCCTGGCGCGGCGCGGCGCCGGCCGGCCGCACCGGCCGCGGCCCCCGCGGCGGTGTGA	MASSPSVLIVGAGPTGLALAAELSAAGIACRVLDKRSTPSPHSRAFGLLPRTLELLDMRGRAESFVAQGLPWAHAALGDGKRWLDYRDVDSPFPYMLVIPQSRTEEQLTSWALDSGAVIERGATVTGLRQHDGGVEVEVEGPGGPRTEHADFVVGCDGVHSTVRELAGISFSGSSYDSSLIVADVRLATPPDPQVYARTGKRGMVVLFPFGDGTFRLIALDHARMGAPVDEPVTVDELRESCRAVLGTDFGLHDPLWMSRFRSDQRLSDRYRLGRVLLAGDAAHTHIPSGGQGLQTGIQDAMNLGWKLAAHLSGRAPAHLLDTYQRERRPIAAATLRRTDLVYKFEVSDSAGARLLRGLSTRLMGLAPVQNSVLEELSGLKLRYRPLAGTTGRVPHRLVGRRVHDTALRSRDGVDSRLYTHFRTGGFVLLDQSHGGFCAEVAEAGWADRVTAVRSVSVGRKNPKDLPEALLVRPDGYVAWAGHAGDTPGLRAALHHWCGEPEAPGAARRRPAAPAAAPAAV	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	110.15	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1410	rifampin
BGC0000422.1|Saframycin_20 # 17903 # 18502 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.745	BGC0000422.1|Saframycin_20 	17903	18502	-	Loose	550	44.669	RlmA(II)	27.84	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGCGGATCCCGGGCACGTCGACACCTTCAACCGGATCGCACCGCGGTACGACGCCAAGTTCGGCAAGGACTGCGAGACCGCCCACACCGTCGTACTCGACTGGGCCGCCCAGGCGGGCCTGGAGCCCCGGTCCGTACTCGACGTCGGCTGCGGCACCGGAAAGCTGCTGGAGGAGGCGGGCCGCCGCTGGCCGCAGGCCCGCCTGTACGGCGTCGACCCCGCCGACCGCATGGTGGAGATCGCCCGGGGGCGGCTGCCCGGCGCCGAGCTGACGGTCGGCCGCGCCGAGCGGCTGCCGCCGGCCGACGCGAGCGTCGACCTCGTGGTGAGCACCACCGCGTTCGGCCACTGGTCGGACGCCCCGGCGGGGCTGCGGGAGATACGCCGGATCCTGCGCCCGGGCGGTTCCGTGATGATCGCCGAGCACGCCCCGCCCGGAGTGCTGCTCCGGCTGCTGCTCAAGGCCATGGGGCGGCTGCCCCGGCTGTACGACGTCGACGGGATGCGCACGCTGGTCGCGGACGCCGGTCTCACCCCCGAGCGTCTGGAGACCGTCCCCGGCACCTTCGTCGTCACCCACGCGACCCGCAACGGCTGA	MADPGHVDTFNRIAPRYDAKFGKDCETAHTVVLDWAAQAGLEPRSVLDVGCGTGKLLEEAGRRWPQARLYGVDPADRMVEIARGRLPGAELTVGRAERLPPADASVDLVVSTTAFGHWSDAPAGLREIRRILRPGGSVMIAEHAPPGVLLRLLLKAMGRLPRLYDVDGMRTLVADAGLTPERLETVPGTFVVTHATRNG	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	70.57	gnl|BL_ORD_ID|2052|hsp_num:0	2274			291	561	tylosin; mycinamicin
BGC0000422.1|Saframycin_21 # 18655 # 19137 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.729	BGC0000422.1|Saframycin_21 	18655	19137	-	Loose	400	29.261	vatE	28.81	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGAGCGTCTGGCACAAGATCGACGACTACCTGCACCTCTTCAGCAGCCCGGTGCTCTCCTTCCGGGACCCCGACGGCTTCCCCTTCAGCCTGCGCTGCCGTCCCCGGCAGGACCGGGACACGGGTCTCATGGTGGTCCGGCTGCCGGAGGGCGTGCCGGCCGCGGAGGGACCCGCGTGGCTGCTGTGGCACAGCCACGACGAGGAGTTCGGCTCGTTGCAGGCCCTCGCCGTCTCCGGTGACCTCGCCGCCCACGGCGACGGCTGGTCCTTCCGGCCCCGGCGGGTGCTGCCGGGGCCCGGTCTTGGACCCGGGGGCTGGGCGGGTGTCGTGGAGAAGATCGAACGGGACACCGCGCGGTTCCTGGAGGAGCGGAACCTGACCGCCCCCCAGGACATCGACTGGGCGGCCCTGGAGCGGATCGCCGAGAGCGCCCGCAAGGACAACGAGGAGCGCGCCCGCGCCTGGGCCGAGCTGCCCTGA	MSVWHKIDDYLHLFSSPVLSFRDPDGFPFSLRCRPRQDRDTGLMVVRLPEGVPAAEGPAWLLWHSHDEEFGSLQALAVSGDLAAHGDGWSFRPRRVLPGPGLGPGGWAGVVEKIERDTARFLEERNLTAPQDIDWAALERIAESARKDNEERARAWAELP	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	74.77	gnl|BL_ORD_ID|1398|hsp_num:0	1519			297	465	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000422.1|Saframycin_22 # 19134 # 19529 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000422.1|Saframycin_22 	19134	19529	-	Loose	590	25.0238	CGA-1	37.14	3004766	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CGA beta-lactamase	ATGGCCTTCCTCTGGAAGCCGGAGGAGAACGAGTTCGTCCTCAGTTCCAGCATCTCGGTGGCCCGGAAGGCGGAGCACATCAACCGCGACGACCGGGTCTCCCTCCTCATGTCCGATTTCACGGGCAGCGCCCTACCCGGCAGCGCTCCCGCCGTACTCGTGCAGGGGCGGGCCACCGCCCCAGAGGAGATCATGACCGTGGACGGCCTGGAGGACTTCTGGGCGGAGCTGTTCCGCAAGCGTCCCGCCGGCGCGCTCGAGGCGCTCGACCCGCGGATCCGCGCGCAGTTCCATCCGAGTTTCTACTGGCGCCTGCGCATCACGGTGACGCCGGAGAAGGTCTGGGCCTTCCGCAAGGACGCGATGGGCGGCACCGCGCTGGAGCGTGTGGCATGA	MAFLWKPEENEFVLSSSISVARKAEHINRDDRVSLLMSDFTGSALPGSAPAVLVQGRATAPEEIMTVDGLEDFWAELFRKRPAGALEALDPRIRAQFHPSFYWRLRITVTPEKVWAFRKDAMGGTALERVA	MKKTTLLFLLISAFSLAQTSLLEQKINSIIKNKKATVGVSVLGFENGFKYDKNGDKKLPMQSVFKFHIAAAVLNAVDQGKLSLDQKIMLNQSNLLENTWSPLRDKYPAGNIEIPLSEVIEYTVAKSDNNGCDILLRLLGGTQVVQKFMDSKGVKGFQIKYNEEDMHKDWNVQYENYSTTKSAADVLKKLYDGKLLSKKSTDYLMKVMLSTSTGLNKMVEQLPKNTPVARKTGASGKNNAGLTGAENEIGIVTLPNGKHYALAVFVSNSMETDAVNCRMISDISKEVWEYFNK	44.86	gnl|BL_ORD_ID|2529|hsp_num:0	3568			231	336	
BGC0000422.1|Saframycin_23 # 19815 # 21002 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703	BGC0000422.1|Saframycin_23 	19815	21002	+	Loose	750	31.9574	tet(49)	31.17	3004582	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACAACGACGCCCGCACCCAGCTACCCCTTCCCCGCGAAATACCTCGACGAGGCCGCCGAACTGGCCAGGCTGCGCCAGGAGGAGCCCATCTCACGGGTCACCATGCCCTACGGCGGCGAGGCCTGGCTGGTGACCCGTATGGCGGACGTCAAGGAGGTGCTCGCCGACCCCAGGTTCAGCCGTCAGCTGCAGACCGAGGCGGACCGCCCGCGCTTCTTCCCCGAGCCCGTGGTCGAGGGCATAGGCATCATGGACCCGCCGGAGCAGACGAGGCTGCGCCGGCTGGTCGCCAAGGCGTTCACGGCGCGCCGGGTCCAGGAGTTCGGGCCGCGCGTGCAGACGATCGTCGACGAACTGCTCGACGCGGTCGAGGCCAAGGGCGCCCCCGCCGACCTCTACGCCGACTTCTCCTGGCAGCTGCCGGGCATCTCCATCTGCGAGTTCATGGGCGTCCCCTACGAGGACCGGGACCGGTTCGTGCCGTTCTTCGACTCGGTCGTCTCGACCACGTCCAAGACCCCGGACGAGATCCGCCAGGCCATCGGCGACCTCCACGCGTACTTCGGCGAGCTCATCGAGAGGCGTCGCGCCACCCCCGGGGACGACCTGTTCACCGCTCTGATCCGGGCGCGCGACGAGGACGACCGGCTCTCGGAGAAGGAGCTCATCGAGATGAGCTTCGGCCTCCTCGTCGCCGGCATGGAGACCACCGCCTCCCAGCTCGCCAACTTCCTCTACCTGCTGTTCCGCAACCCCGACCAGCTGGAGCTGCTGCGCGCCAAGCCCGAACTGGTGCCGAACGCCGTCGAGGAGCTGCTGCGCTTCGTGCCGCTGCTCGCCGTCGACCAGCCGTCGGTGGCGCGCGAGGACGTCACCCTGGGCGGCGTGCTGATCCGGGCCGGCGAGACCGTGGTCCCGTCGATGAACTCCGCGAACCGCGACGCCGACGTCTTCGAGAACCCGCAGCGCATCGACGTCACCCGGGAGAACAACCCGCACCTCGCCTTCAGCCACGGAGCGCACCACTGCGTGGGCGCCCAGCTGGCGCGGATGGAGATGGTCACGGCGCTGCGCTCCCTGCTGGTGCGCTTCCCCGGCCTTCACCAGGCGGTGCCGGACGAGGAGCTCCGCTGGAAGGCCGGGGTCGTCCTGCGGGGCGTCGAGGCGCTGCCGGTGGCGTGGTAG	MTTTPAPSYPFPAKYLDEAAELARLRQEEPISRVTMPYGGEAWLVTRMADVKEVLADPRFSRQLQTEADRPRFFPEPVVEGIGIMDPPEQTRLRRLVAKAFTARRVQEFGPRVQTIVDELLDAVEAKGAPADLYADFSWQLPGISICEFMGVPYEDRDRFVPFFDSVVSTTSKTPDEIRQAIGDLHAYFGELIERRRATPGDDLFTALIRARDEDDRLSEKELIEMSFGLLVAGMETTASQLANFLYLLFRNPDQLELLRAKPELVPNAVEELLRFVPLLAVDQPSVAREDVTLGGVLIRAGETVVPSMNSANRDADVFENPQRIDVTRENNPHLAFSHGAHHCVGAQLARMEMVTALRSLLVRFPGLHQAVPDEELRWKAGVVLRGVEALPVAW	MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQEVAEERSNKIMQEVEIAANMISLPNYE	102.07	gnl|BL_ORD_ID|2695|hsp_num:0	3285			660	867	tetracycline; oxytetracycline
BGC0000422.1|Saframycin_26 # 22963 # 24234 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000422.1|Saframycin_26 	22963	24234	-	Loose	1900	28.1054	acrD	33.33	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGGCCGCAACCCGCGCACGGTCTTCGCGTTCGGGCCCGACCAGGCACGCCAGGTGCTGACCGGGAAGTCCTTCGTCTCGGACTCCTTCCGCCACCTGCGCCTGCCGCCCGGCTCGCCGATGATGCTGCTGACCAGTGGGCTGCTGCGGCTGAACGGCACCATCCACCGCAAGCACCGTCAGGCCATGCAGCAGGCCTTCTCCCCGCGCCACGTCACCGTCTACACCGACACCATCGTGCGCTTCGCCGACGACATGCTGGACGGGTGGACGCCGGGCCGTTCCGTGGACCTGCACGAGGAGCTCGCCCGCCTCGTGACGCGGATCTCGCTGGCCACCATGGCCGGTCTGGAGGACGAGGCGGCGGCACGCCACCTCAACGACAAGATGGTCGAGCTGGCTGCCGCGGCGGGGCACCCGCTCACGGCGGTGATACAGGCACCGCTGCCCGGTACGCCCTTCCGCCGCATGACCCGGATCGCGGGCGAGATCGAGGACATCCTGCGCGCGCTGATCGCCGCACGGCGCTCCGGAGCGGCCGCGCCCGACCTGCTGAGCAAGCTGACCGTGCCCGACGCGGAGGCCGACGCCGAGGAGTTGAGCGACGAGGAGCTGCTGGGCGAGGCGTACACCGCGCTGTGCCACGACAGCGTCGCCTCGTCCCTGTTCTGGACCCTCTTCCTGCTCGACCAGCACCGGGAGTGGTGGGAGAAGCTGCGCGCCGAGGTGGCGGAGGTCGCGGGTGACGCGGCTCCGGGACCGGACGTGCTCGTACGGATGCCCGTGCTGGACCGGATCGTCAAGGAGAGCGTGCGGCTGATGCCGCCGGCCGGATTCGGCGTGCGCTACGCGGAGGAGGGCGCCGTGATCGACGGCCACCCGATCCCCAAGGGCGCCATGACGATCTTCAGCTCCTTCGTCACCCACCGCGACGCCGGGACGTTCCCCGAGCCCCTGCGCTTCCGCCCGGAGCGCTGGGAGACCGCCCAGCCCTCGCAGCACGAGTACTTCCCCTTCGGTCTGGGCCAGCACAACTGCATCGGGCGCAACCTCGCCCTGCTGGAGAGCAAGCTGGTGCTCACCCGCATCATGCAGCGCGCACCTGTCGTGCTGCCCGCCGGGACTGTGGTGGATCCCGTCGTGCGGATCTCCACGGTCCCCGACGGGCACGTCCGGGCCCTGGTGGCCGGGCCGGACGGGCCGGCTCCGCGGGCGTACCGCGTCACCGGATCGGTGAACGAGATCATCGAGCTGCCGGAGCACCCCTGA	MPGRNPRTVFAFGPDQARQVLTGKSFVSDSFRHLRLPPGSPMMLLTSGLLRLNGTIHRKHRQAMQQAFSPRHVTVYTDTIVRFADDMLDGWTPGRSVDLHEELARLVTRISLATMAGLEDEAAARHLNDKMVELAAAAGHPLTAVIQAPLPGTPFRRMTRIAGEIEDILRALIAARRSGAAAPDLLSKLTVPDAEADAEELSDEELLGEAYTALCHDSVASSLFWTLFLLDQHREWWEKLRAEVAEVAGDAAPGPDVLVRMPVLDRIVKESVRLMPPAGFGVRYAEEGAVIDGHPIPKGAMTIFSSFVTHRDAGTFPEPLRFRPERWETAQPSQHEYFPFGLGQHNCIGRNLALLESKLVLTRIMQRAPVVLPAGTVVDPVVRISTVPDGHVRALVAGPDGPAPRAYRVTGSVNEIIELPEHP	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	40.79	gnl|BL_ORD_ID|1309|hsp_num:0	1427			2469	2571	
BGC0000422.1|Saframycin_27 # 24300 # 24623 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.648	BGC0000422.1|Saframycin_27 	24300	24623	-	Loose	300	24.2534	tet(W/N/W)	39.13	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACATACGCCGCGTTCAGCGGGGTGGGGGGAAAGTCCGCTCCCGAAGCCCGCCTTCCCGAAGCTAAAGGGGGCCCGGACCCTCCGGAGAATTTCTTTCAGAACCATGAGGGATTCCCGAAAGAAGTCGCCGAGGACCATCTTGCGGGGTTCTTTCGGCCGGCGGCTCGGGCGGGCGGCGGTGGGGTACAAGGAAGAGTCTTCATCCATGCCGTTCCCGGAGGAGAATCACCGTGCCTGGAACCCCTGTTGTGCAGAATCCGGCGGACCGACTGGCCGGACCGGCAGATCCTCTCGGGTTGCGCAGGCTCTCGGCCGGACTGA	MTYAAFSGVGGKSAPEARLPEAKGGPDPPENFFQNHEGFPKEVAEDHLAGFFRPAARAGGGGVQGRVFIHAVPGGESPCLEPLLCRIRRTDWPDRQILSGCAGSRPD	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	16.74	gnl|BL_ORD_ID|2492|hsp_num:0	2882			693	762	tetracycline; minocycline; chlortetracycline
BGC0000422.1|Saframycin_28 # 24645 # 29924 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=4bp;gc_cont=0.757	BGC0000422.1|Saframycin_28 	24645	29924	+	Loose	1000	128.642	almE	25.91	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCAGGCGAGCACGGGCCGGGAGACTGTTCTCGGGGCCATTCGGGCCGTGTGCGAGACCGACCCGGGTGCGACGGCGGCCGTTTTCCCCGCCCAGCCGGCGATCGGTCTCACCGAGGCGGTCACCTTCAGCCGCGAGGGACTGGACCGCGAGGCCCGGGCCCTCGCGGTCAAGCTGCGCGAGGTGGCCGAGGGCCCCGTACTGCTGCTGATGCAGCCCGGCCCGGACTACCTCAAGGGGTTCCTGGCCACGGTCTACGCGGGACTGCCAGCCGCACCGGTCTACCCGCCCAACCCCGCCGACGTGCGCCGCGACTTCATCCGGCTCGGCGCGATCCTCGCCAAGCTGCCGGACGCCACCCTGCTGACCGAGCCGGGGCTGCTGGAGCCGCTGCGCGAGCTCTTCGCGGAGCGGCTGCCCGACGTACGTCCCGAACGGCTGGTGGACACCAGCGTCCCGGCCGGCGCCGAGGACGACTGGCGGGCGCCCGCGGTCCGGCCCGAGGAACCGCTGTTCATCCAGTTCACCTCCGGTTCGACCGGCACCCCCCGCGGCGTGCTCGTCTCGCACCGCAACCTGCTCGCCAACGTCCGCGCCATCACCGACCGGTTCGGCCTGGACACGTCGAGCACCGGTGCCCTGTGGCTGCCGCCGTACCACGACATGGGACTGGTCGGCGGAGTACTCACTCCGCTCGTCAGCGGCTTCCCGATCCACCTGCTCTCGCCGCTCTCCTTCGTCTCCGACCCGATGGGCTGGCTCCGGCTGGTCTCCGAGACCGGAGCCACCCACACCGGGGCGCCCAACTTCGGCTACGCGCTGGCCACCCGCCGCGCCCGGGACGAGGACGTGGCCGCGCTCGACCTCAGCCGACTCCAGGTGGCCTTCTCCGGTGCCGAGCCGGTGGACGCCTCGACCCTGCGCGCTTTCGCCGAGCGCTTCGCCCCCGCCGGCCTGAGCCCGGACGTCTTCCTGCCCTGTTACGGGCTCGCCGAGTCCACCCTGATCGTCAGCGGCGGCCGCCCCGGCGCCGGACTGCGTACGCACCGGCTCGACCCCGAAGCCCTGGCACTGGGCAGGGCCGAACCGGCCCGGCCCGGCGCCCCGGCCACCGAACTCGTCTCCAGCGGCCCGGTGGTGGCCGGCACCGAGGTACGGATCGCCGACCCCGTCACCGGGGCGGCGGCCGGACCCGGCGAGATCGGCGAGGTCTTCGTCGCCTCGGACAGCGTCGCCGAGGGGTACTTCGAGGACCCCGAGGAGACGGCGCGCACCTTCGGCGCGACCCTGGCGGGCTCGAGTCGCAGCTGGATGCGCACCGGCGACCTCGGCTTCCTCGGCGCCGACGGCGACCTCGTGCCGGTCGCCCGGATCAAGGACGTCATCGTCGTCCGCGGCCGCAACCTGCACCCGCAGGACATCGAGCGGACGGTGCAGGACACCGACCCCGGGATCCGCAAGGGCTGTGTCGCGGCCGCGGGCGTACCCGGCCCGGACGGCGGGGAGGAGATCCTGGTCGTGGCGGAGCTGCGGCCCGAGGCCGCGGACGACGAAGCCCAGGCCCGCAGGATCGCCCGGGAAGTCCGCGCAGCCGTCGCACGCGAGCACTCCGCCCCGGTGCGCGGCATCCACCTGATCCGTCCCTCGACCCTGCCCAAGACCTCCAGCGGCAAGGTGCAGCGCTCCGCCGCCCGCGCCGCCCACCTCGACGGCTCCCTGGCCACCGTCCTGTGCGACACCGCCGACACTGCGGCGCCGACGGGCGCGCCCCTCCCCGCCGGGCCCGCAGCGGGCGGCTCCGACGACCTCGTCGTCAACCTCGCAGCGACGGTCATCAGGCACTTCGTCGGCCACGGCGGCACCACCGGCGCACTGGACTCGCTCGGCGCGGCCCGGCTCGCCGGGGAGGCGTCGCAGATCTTCAAGGTCGCCCTTCCCGTCACCGACATCCTGGCCGGTGTCGACGCCGAGGCGCTCGCCGCGCTCATCCGGACCGCCGCCCCCCTCGGCGGCCCCGCCGCCGCAACCGGCTCCGCCGGGCTGGCCGAACTCCCCGCGACGGCACGCCAGGAAACCCTGTGCCTGCTCCAGGAACTCGACCCCGCCGCCCCCGGCCTCGCCCTCGGCATCGCCTTCGCCCTGCCCGCCACGGCCGACCCGCAGCGCGTCGCCCTGGCCCTGACCGCTCTCGTGGCCCGCCACCCGGCACTGCGCACCCGCCTGGTGCGCCGCGGCGAACACTGGTCGCGCCTCGTCGACCCGGCCGACACCGCCGCCGGTGCGCCCTGGGGCCGGTACTGCACCCTCACCCGGCTCGGCGGGATCGGGGAGCGGGACCTCGAAGAGGCCCTCGCCGAGCGCTGCCGACGCGTACCCGATCTCGCCGAAGGCCCGCTGTTCCAGGCCGAGGTCGTCCTCGCGGACGGGCACGGCGCCCACCTGGTGATCACCGTCCACCACGCCGTCGCCGACCTGTGGTCGATCGGTGTCCTGGCGGCCGAGCTCGCCCACCTGCTCGCCGCCGGTGATCCGGAGGCCGGGGCCCTGACCCTCCCGCCGGCCCCGGAGGTCTCCTGCGACGTCCCCGACGACCGGCGCCTGGAACGGGCGTGGAACTTCTGGCAGGGACTGCTCACCGACGGGTGCGGCCCCCTCCAGCTGCCGTCCGCCGACGGCCCGGCGCAGAACGTCCCGGCCGGCCGCGCGCGGCAGGCCAGCCACGCCCCGCTCACCCTGGACGCCCGGCGCACCGCCGCGCTCACCGCCCTCGCCAAGGAGTGCGGCGTCACCCTGTACGCGGTCCTGCTCGCCGTGCAGTCGCTCACCCTGTCCCGGCTCACCGGAACCGACCGCGTCCCGGTCGCCGTACCGCTGCACGGCCGGGGAAGCGCCACGCACCGGGCCGTCGACTACCTCGTGTCCACGGTCACCCTGCCGATGGAGACCGCCACCGGCACCGTCCGCGACCTGGTCGGCCGTGCGGCCGACGCCCTGCGCGGCGCGCTCGCCCACCGCACCGTCGGCTACCCCGAGCTGGTGGCCCTGTCCGCGGCCCGCGGCGGCCCCGACGTACCCGCCCCCGACGCGGCGCTGCTGCTCCAGCAGGACACCCCCGGCGCACCGCGCGGGGTCGGCGCCGGCCTCCTCGGCGGCGGAGTGCGGCTCGGGGACGTGGAACTGGGCGTCGCCGTGGTCCCGCCCAGCATCGGCCCCTTCGGCCTGACCACCCTGCTCACGGAGACGGACGGCACCCTCACCGGGCGCGTCGAGGTCGACCCCAGCCGCCATGCCGACTGGCTGGCAGGCCGGTTCGCCGACGCCTTCCTCGCCATCGCCGACTCGGTGGCCGCCGGCGCAGGACTCCCCCTCGCGGAGGCGTCCGCGGTGGGGGCGGAACAGGCCGAACGGCTGCGCGGCTGGTCGCGCTCGCCCGTGCCCGAGGACGGCGAGGGCACCCTGCACGACCTCGTCCTGTCAGCGGCGGCCCGCCACCCGCGGCGCACCGCGGTGGTCGCCGGCGACGGGAGCCTCAGCTACGGCGAACTCGCACACCGCTCGGCCGTCGTGGCGGCCGCGCTCGCCGCGGAAGGCGCCGGCCCCGGCTGCACCGTCGGCGTGCTGATGCAGCGCGGCCGCGACCTGCCTGCGGTCCTGCTCGGAGTACTGCGCTCCGGCGCCGCCTACCTGCCCCTGGACGCGGCCACTCCGCCCGCCCGGCTGGCCGCCGTGGTCGAGGACGCCGGCTGCCGCCACGTCCTGGTGGGCGACGTCCCGGTGGAACGGGGGCAGTTCTTCCCCGTCCGCACCCTGGACGTGGACGCGGTCCTCGCGGCGGGCCCGGCCGAGCCGGTGCCGCCGCGGCCCCTGACCACCCCCGACGACCCCGCCTACCTGCTCTTCACCTCCGGCTCCACCGGCCGGCCCAAGGGCGTGGTGATCCCGCACCGCGGACCGGTCAACCTGATCCGCTGGGCGGGCCGGGAGTTCGGCACGGACGCCCTCGCCCGCACCCTCGCCGTCACGCCCACCACCTTCGACCTGTCCGTCTTCGAACTCTTCACGCCCCTGGCGCACGGGTGCGAGGTGCGGCTGCTCGACGGCGTCCTGGACCTGGTGGACAGCCCCGCGCACGCCGCCGACGCCACCCTGCTCAACACCGTCCCCTCGGCGGTGGCGAGCCTGCTGGAACAGGACGCGCTTCCCGCCGGCCTCAGCGTGGTCAACGTGGCGGGCGAACCGCTCACCGCCGAACTCGTCCACTCCGTGCACCGGCGCCTTCCCGGTGTCCGCATGGTCAACCTCTACGGCCCCAGCGAGACCACCACCTACTCCACGTACGCCGAACTGGGCCCGGACACCAGCGGCGCCGTCCCCATCGGCCGACCCGTCGGCGGCACCACCCTGAGCGTCGTCGACGCCTCCCTGCGGCCGCTGCCGCAGGGAGCCACCGGCGAACTGCTCATCGGCGGCGCGGGCGTCGCCGTCGGATACGCGGGGCGCCCGGGCATGACCGCGGCCCGGTTCCTGCCCGACCCCGAACACCCGGGCCGCAGGCTCTACCGCACCGGCGACCTCGTCCGCTGGCGGGCCGACGGCCTGCTGGAGTTCCTCGGGCGCTCCGACCACCAGGTCAAGGTCCGCGGCTTCCGCATCGAACTCGGCGACGTCGAGCGCGCGCTGACCGGCCTCGACGCGGTCCGGGAGGCCGTCGTCGTCGCCCTGGGCCAGGGCACCGACCGCCGCCTGGCCGCCTACCTCGTGCCCGAGCGGCCCCTGGAAGGCGACCCCGGCAGCTGGCTGCGCGGCGTCCGCCGGCGCCTCGGCCACGAACTGCCCGGGTACATGGTGCCGGGCGAGTTCGCGGTACTCGACGAACTGCCGCGCAACCGGCACGGCAAGCTCGACCGCGGCCGGCTCGCCTCCACCGCCACCGTTCCGCTCGTCACGGGCAGCCGGATCGCCCCGCGCAACGACAGCGAGCGCCGTGTCGCGGCCTGCTGGGCGCAGGCACTGCCGGTTCCCGAGATCGGCGTGACCGACGAGTTCCTCGACGTCGGCGGACACTCCCTGATGCTCACCACGATCGCGCACCTGATCGCCAGGGAGTTCTCGGTCCAGGTCCCGCTGACCGCCCTGCGCACGCACACGACGGTGGCCGAACAGGCCAGGTACCTCGACGAGCTCACCTCGGCCGCGCCCCCGCACGCCGCAGGCCCGCGGTCCGTGCGACGCCTGGACCGCAGCAGGTACACCGCGGCCGGGAACGGCCGGACCACCTGA	MQASTGRETVLGAIRAVCETDPGATAAVFPAQPAIGLTEAVTFSREGLDREARALAVKLREVAEGPVLLLMQPGPDYLKGFLATVYAGLPAAPVYPPNPADVRRDFIRLGAILAKLPDATLLTEPGLLEPLRELFAERLPDVRPERLVDTSVPAGAEDDWRAPAVRPEEPLFIQFTSGSTGTPRGVLVSHRNLLANVRAITDRFGLDTSSTGALWLPPYHDMGLVGGVLTPLVSGFPIHLLSPLSFVSDPMGWLRLVSETGATHTGAPNFGYALATRRARDEDVAALDLSRLQVAFSGAEPVDASTLRAFAERFAPAGLSPDVFLPCYGLAESTLIVSGGRPGAGLRTHRLDPEALALGRAEPARPGAPATELVSSGPVVAGTEVRIADPVTGAAAGPGEIGEVFVASDSVAEGYFEDPEETARTFGATLAGSSRSWMRTGDLGFLGADGDLVPVARIKDVIVVRGRNLHPQDIERTVQDTDPGIRKGCVAAAGVPGPDGGEEILVVAELRPEAADDEAQARRIAREVRAAVAREHSAPVRGIHLIRPSTLPKTSSGKVQRSAARAAHLDGSLATVLCDTADTAAPTGAPLPAGPAAGGSDDLVVNLAATVIRHFVGHGGTTGALDSLGAARLAGEASQIFKVALPVTDILAGVDAEALAALIRTAAPLGGPAAATGSAGLAELPATARQETLCLLQELDPAAPGLALGIAFALPATADPQRVALALTALVARHPALRTRLVRRGEHWSRLVDPADTAAGAPWGRYCTLTRLGGIGERDLEEALAERCRRVPDLAEGPLFQAEVVLADGHGAHLVITVHHAVADLWSIGVLAAELAHLLAAGDPEAGALTLPPAPEVSCDVPDDRRLERAWNFWQGLLTDGCGPLQLPSADGPAQNVPAGRARQASHAPLTLDARRTAALTALAKECGVTLYAVLLAVQSLTLSRLTGTDRVPVAVPLHGRGSATHRAVDYLVSTVTLPMETATGTVRDLVGRAADALRGALAHRTVGYPELVALSAARGGPDVPAPDAALLLQQDTPGAPRGVGAGLLGGGVRLGDVELGVAVVPPSIGPFGLTTLLTETDGTLTGRVEVDPSRHADWLAGRFADAFLAIADSVAAGAGLPLAEASAVGAEQAERLRGWSRSPVPEDGEGTLHDLVLSAAARHPRRTAVVAGDGSLSYGELAHRSAVVAAALAAEGAGPGCTVGVLMQRGRDLPAVLLGVLRSGAAYLPLDAATPPARLAAVVEDAGCRHVLVGDVPVERGQFFPVRTLDVDAVLAAGPAEPVPPRPLTTPDDPAYLLFTSGSTGRPKGVVIPHRGPVNLIRWAGREFGTDALARTLAVTPTTFDLSVFELFTPLAHGCEVRLLDGVLDLVDSPAHAADATLLNTVPSAVASLLEQDALPAGLSVVNVAGEPLTAELVHSVHRRLPGVRMVNLYGPSETTTYSTYAELGPDTSGAVPIGRPVGGTTLSVVDASLRPLPQGATGELLIGGAGVAVGYAGRPGMTAARFLPDPEHPGRRLYRTGDLVRWRADGLLEFLGRSDHQVKVRGFRIELGDVERALTGLDAVREAVVVALGQGTDRRLAAYLVPERPLEGDPGSWLRGVRRRLGHELPGYMVPGEFAVLDELPRNRHGKLDRGRLASTATVPLVTGSRIAPRNDSERRVAACWAQALPVPEIGVTDEFLDVGGHSLMLTTIAHLIAREFSVQVPLTALRTHTTVAEQARYLDELTSAAPPHAAGPRSVRRLDRSRYTAAGNGRTT	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	316.37	gnl|BL_ORD_ID|4935|hsp_num:0	5928			255	1617	colistin A; colistin B
BGC0000422.1|Saframycin_29 # 29983 # 33309 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.749	BGC0000422.1|Saframycin_29 	29983	33309	+	Loose	1000	167.162	almE	29.22	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAGCGACCGGATCCCACCCGACGCCCATCTCTTCCCCGCCTCCCCGGGACAGGAACGGCTCTGGTTCCTGGACCGGATGAACGAGATGGCCGGCAAGGCGTACGGCCTCGCCGTCCGCCTGGACCTGCGCGGCGCCCTGGAGCGCACCGCCCTCCAGTCCGCCCTCAGCGCCGTCGTCGAACGCCACGAGGCCCTGCGCACCGGCCTGCGCCAGATCGACGGCACGCTGACGCAGGTCGTCGTCCCCGGCGTCACCGTCTCGCTGCCCGTCGTCGACCTCGGCGGCCGCGGACCGGACCCCGCGCAGCTCGACCGCGAGGTGCGGCGCCTGGCACGCCAGGAGGCCCAGCGCGGCTGGAACCTGGCCCAGCCGCCCCTGCTGCGCGGGCTGCTGGCCCGGCTCGCCGACGACCACCACGTCCTGCTGCTGTGCGTGCACCACGCCGTGTGCGACGGCCTGTCCCTCCAGATCGTGCTGCGCGAACTGCTGGAGAACTACACCGGCGGCGGTCCCGCCGGTGCCGACGAGCCCCTCCAGTTCGCGGACTACGTGGTGTGGAACAACGGCGGTGAGGAGTTCCCGGACCCCGAGTGGTCCGCGCGCCGCCAGGCCGCCCGGGAACACTGGAGCAGCACCCTCGCGGGCGCCCCCCAGGTTCTCGACCTGCCCACCGACCGGCGCCGGCCGCCCCTGCAGTCCTACGCCGGAGCCCGCGTTCCCGTCCGGCTGGACACCGCGTTCGCCGACCGGGTGCGCGACTGGTCCGCCCAGCGCGGGGTGACCCCCTTCACCACGCTGCTGGCCGCCTACACCGTCGTCCTCGCCCGCAACGGCGGCGCCGACGACCTGCTGGTCGGCCTGCCCGTCGCCAACCGCTCCCACGCGGACCTCGCCGGGACGGTCGGCTACCTGGCCAACACCTGCCCGCTCCGCGCCGACCTGCGCGCCGACCCCACCCTCGGCGAACTGGTCCGAGACCTGTACGACCGGCTCACGGGCGTCCTCGAACACGCCGACCTCCCCTTCGGCGAGCTGGTGGAACTGCTGGCACCGCCGCGCATGCCCGAGCGCAACCCCGTCTTCCAGGTCATGTTCGGCCTCCAGCAGGACGTCCGGCGCGGCTGGGACCTGCCAGGCCTGCGCGTGGACGTCGAGGACGTGGACTGCGGCAACGCCCGCGTCGACCTGTCCCTGTTCCTCTTCGAGGAGGCTGACGGGGCGATCGACGGATTCCTGGAGTACGCCTCGGCGCTCTTCGACCGCGCCACCGCCGAGCGCTTCGCCGACCAGCTCCACACCGTGCTCCGGCAGATCCTGCGGGACGCGCGGATCCCCGTCTCCGCCGTCGACCTCGTCGGCAACGGCTCCGCCACCACCATCGACTCCTTCCTCGACGGCGGGCCGCTGGAACAGCCCTGGCCGCTGGTGTGGCCGCGGATCCGCGAACTCGCGGCGCGCCGTCCGTCGGCCGAGGCCGTCCGCGACGACGCGGAAGCCCTGGACTACGCCTCGCTCGTCGACCGCGTCGACGCCGCCGCCGCGCGGCTCACCGCTGCCGGCGCGGGCCCCGGCGACCGCGTCGCCGTCCTCGCCGAACGCGGCGTCCGCGCCGTGGTCGCGATGCTCGCCTGCTGGCGTGCCGGCGGCGTGTACGTGCCCGTCGACCCGGCGGCCCCGCTGCCGCGCCGGGAGCTGATCCTCGAACAGGCCGCTCCCGCCGTCCTCGTCTGCGAGGACCCCGACGAGCAGCCGCCGCACCACCGGAGCCGAGCGGTGGCGATCGGCGACCTCACCGCCGAGGCGGACGCCGGTGCGGGCACACCGGCGGAGCCGGCCCCGCGGCCGCACGATCCCGCGTACCTGATGTTCACCTCCGGCTCCACCGGGCGCCCCAAGGGCGTGGCCGTCAGCCACGCCAACCTCTCCTCGTTCCTGCACGCGCTGACCGGCCGCCTGGCACTGGGGCCGGCCGACCGGCTGCTGGCGCTGACGACGACGGCGTTCGACATCTCGCTGCTCGAACTCCTCGGCCCGCTCGTCACCGGCGGCACCGTCGTCGTGGCACCCTCCTCCGCCCAGCGCGGCGCCGCCGACCTCGCCGCCCGGCTCAGCTCCCCCGGAATCACCACCGCCCAGGCCACACCGGCCGTCTGGCGCCTGGCCCTGTCCGCCGGATGGCGCCCCCGGGAGGGCTTCACACTCCTGTGCGGAGGCGAGGCACTGCCCCCGGACCTCGCCGACCTGCTGGCCGCCACCCCCGCCGAGGCCCACAACCTCTACGGTCCGACCGAGACCACCATCTGGTCCTGCGCCGCCCGGATCCGCCCGGGTGAGCCCGTCACCATCGGCCGTCCCATTCCCGGCACCCGCGTCCTGGTGGCCGACGCCGCGCTGCGGCCCGTACCGCCCGGCGTCTGCGGCGAACTCCTCGTCGGCGGCCCCGGAGTGGCCCTCGGATACCTGGACGACCCCGCCCGCACCGCGGCGCGGTTCGTGCCCGACCCCTACCACCCCGGCGAACGGCTCTACCGCACCGGCGACGTCGTACGCCTGCGCTCCGACGGGTTGATCGAGTTCGTGGGCCGCGTCGACGAACAGGTCAAGGTACGCGGCCACCGCATCGAACTCGGCGAGATCGAGAGCGCGCTGCGCGCCCTGCCCGGAGTGCGCGACGCCGCCGCGACCGTGCTCGACCCGCGCGGCAACGCCCGTATCGCCGGCTACCTCGTCGCCGACGACGGCGCCCTCGACACGGCAGGACGGGCGGCCCGGCTGCGTCAGGACCTGTCCGAGGCACTGCCCGCGTCCATGGTGCCCTCCGAGCTGTACGCCGTGCCCGCCATCCCCCTCAACCCCAACGGCAAGGTCGACCGCCGGGCCCTGCCGGGCACCGGTCGGCGCCTGGAGGGCGGCAGCGAGCGCGTCGCCCCCTCGACCGATGCCGAGCACGCCGTCGCCGCGCTGTGGTGCGAACTCCTCAGCCTTCCGGAAGTCGGCGTCCGAGAGGACTTCTTCGGACTCGGCGGCCACTCGCTGCTCGCCGCCGACCTCCTGCAGCGCCTCGAACGCGACCTGGGCGCCCGCGTCCCCGTCGCCGAGTTCTTCATGGAACCGACGGTCGCCCGCCTCGCGGCGACCGTCAGCCAGCTCAGCGGTGCCGTGCACCAGACACCGACCCAAGACCCAGACGGGCGTGCGGAGCAGACCGCAGAGCCCTCGCCCGAGGACCGCGGGGCAGACGGTGACGGATGGGACTTCCCCACCGTGCGCCGGTCCGTCACGGTCCCCGGCTCCGACCCCGTTCCCCTGGAGGTTTCGCCGTGA	MSDRIPPDAHLFPASPGQERLWFLDRMNEMAGKAYGLAVRLDLRGALERTALQSALSAVVERHEALRTGLRQIDGTLTQVVVPGVTVSLPVVDLGGRGPDPAQLDREVRRLARQEAQRGWNLAQPPLLRGLLARLADDHHVLLLCVHHAVCDGLSLQIVLRELLENYTGGGPAGADEPLQFADYVVWNNGGEEFPDPEWSARRQAAREHWSSTLAGAPQVLDLPTDRRRPPLQSYAGARVPVRLDTAFADRVRDWSAQRGVTPFTTLLAAYTVVLARNGGADDLLVGLPVANRSHADLAGTVGYLANTCPLRADLRADPTLGELVRDLYDRLTGVLEHADLPFGELVELLAPPRMPERNPVFQVMFGLQQDVRRGWDLPGLRVDVEDVDCGNARVDLSLFLFEEADGAIDGFLEYASALFDRATAERFADQLHTVLRQILRDARIPVSAVDLVGNGSATTIDSFLDGGPLEQPWPLVWPRIRELAARRPSAEAVRDDAEALDYASLVDRVDAAAARLTAAGAGPGDRVAVLAERGVRAVVAMLACWRAGGVYVPVDPAAPLPRRELILEQAAPAVLVCEDPDEQPPHHRSRAVAIGDLTAEADAGAGTPAEPAPRPHDPAYLMFTSGSTGRPKGVAVSHANLSSFLHALTGRLALGPADRLLALTTTAFDISLLELLGPLVTGGTVVVAPSSAQRGAADLAARLSSPGITTAQATPAVWRLALSAGWRPREGFTLLCGGEALPPDLADLLAATPAEAHNLYGPTETTIWSCAARIRPGEPVTIGRPIPGTRVLVADAALRPVPPGVCGELLVGGPGVALGYLDDPARTAARFVPDPYHPGERLYRTGDVVRLRSDGLIEFVGRVDEQVKVRGHRIELGEIESALRALPGVRDAAATVLDPRGNARIAGYLVADDGALDTAGRAARLRQDLSEALPASMVPSELYAVPAIPLNPNGKVDRRALPGTGRRLEGGSERVAPSTDAEHAVAALWCELLSLPEVGVREDFFGLGGHSLLAADLLQRLERDLGARVPVAEFFMEPTVARLAATVSQLSGAVHQTPTQDPDGRAEQTAEPSPEDRGADGDGWDFPTVRRSVTVPGSDPVPLEVSP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	199.28	gnl|BL_ORD_ID|4935|hsp_num:0	5928			231	1629	colistin A; colistin B
BGC0000422.1|Saframycin_30 # 33306 # 37763 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.738	BGC0000422.1|Saframycin_30 	33306	37763	+	Loose	1000	167.162	almE	27.7	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCCGGCACGAGCCCACCGAGACGTTCACCGACACCCTGCACCGCGTACTCGAAGAACGCGGCGCGGAATCGGCCACCCCGCTGTCCGTGGAACAGCGCCGCCTGTGGCTGCTCGGCGGGATCGCCGACGGCTCCTGGGCCGTCGTCACCGGCCGCTACCGGCTCCAGGGCGTCCCGGACGCCGCGCGGCTCCAATTGCGGCTGGCCTCCCTGGTCTCCCGCCACGAGGCCCTGCGCAGCGTGTTCGTGCAGGTCGCCGAGCGTCCCGTCCGCCTGGTCCTGCCGTTCGCCGAGGTCGCCCTGCGCACGGTGAACGCACCCGACTCCACCGACCCCGCGCGGGCCGACGAGCACGTCCGCCACCTCGTCGAGGAGGAGTTCTCCCTCGGCCACGGACCGCTGCTGCGCGCCCTGCTGCTGCGCTCCGCCGACGGCGGCGCCGCCGAACTCGTCCTCGTCGGGCACCGCCTCGTCCTGGACGCCACCTCACTGGACCTGCTCGTCGCCGAACTGCTCGGCGAGGACGCCCCCCACGGCCGCGAGGGCGCCGCGGACACCGCCGGCGCTCTGGAGACCACCCTCGCGGCGGAACGCGAGCGCCTCGCCGACCCCGCCCTCACGCAAGCGGTGACCGGCCGGGCCGCCGAACTGGCCCTCCCCGCCGCCACCGAGATCCCCGGCTACGGCCGGCGGCCCGAGATCAAGGGCACCTCCTACGCCTCCGTGGCGCTGCCCCTGCCGCTCGCCCTCGCCCCGCGCGCCGCCGAGGCCGCCGACTGGGAGGCCGCGGTCGCCGCCGCCTGGCTCGTGGTCCTCATGCGCTCCCAGGCCACCGGCTCCGCCGTCTGCGGTGTCCGCACCGCCCGCGGCGCGGAGCAGGCCGGGATCGTCGGCCCGCTCGACGGCCTGCGCCTGGTCCGCGTCGACGACGCGGACGACGCGCCGCTGTCGGACCTGCTCGCCGCGGTCGGGCGACAGCTGCGCGCCCCCGCCGTGGACGTGCCGCTCGCACACCTCCTCGAAGTGGCCCCGCCCCGCCGCGACATCAGCCGCACCCCGTACGCCCAGACCGTCGTGCGGGCCGTGGACGCCCGCGAACCGCTCGGCGGGGCGTCGGGCACCGGCCGGCAGATCGGCGGAGCCGCCTCGGGCACCGAGTACGACATCGAGGTGACGGTGCGCCTCCAGCCCGGCCTCGCCGTCGCACAGATCGACTACGACGTCCAGCTGTACTCCGAGGAGCGGGTCCGCGCCCTCGGCAACCAGCTCGCCGCCGTCCTCGACGCCATCCTGCCCGGCGGCACCCCGGAGGTCACCGCCACCGTCGTCCCGCTGCTCGACGCCGAGGGCGCCCGGCTCGCCCTGGAGGCGGGCCGCGGCGAGCGGACCGCGCCCGACACCCGATCGCTCGTCGACCTCGTCGAGGCCCAGGTGGCCGCCGCACCGGACGCCGTCGCCCTGTGGCAGGGAGACACCCGAGTCACGTACGCCCAGCTGTGGGCCGACGCCACTCGCCTGGCCGACGAGCTGGCCGCCCGCGGGGTGCGCCCCGGCGACCGCGTCGCGGTCTGGCTGCGCCGCGGCCCCTCGACGGTCACCGCCCTGCTCGCCGTGCTCGCCGCCGGCGCCGCCTTCGTGCCCGTCGACGCCGCCTACCCCGAGGAGCGGGTGCGCTACCTGCTCTCCGACTCGCGGCCCTCGCTCGTGGTCACCGAGAGCTCCGTGCACCTGCTCGGCGAACTCGGCCTTCCCACGCTGCTGCTGGACGAGCTGTCCGGTGCGCCGGCCGCCGTGGACGGCGCGCGCCGCCCCGACCGGGTCGCCGCCGACACTCCCGCCTACCTCATCTACACCTCCGGCACCACGGGCCGCCCCAAGGGCGTCGTCGTGCGCCACTCCAGCGTGGTCAACAACATTGCCTGGCGCCAGGCGAACTGGCAGCTCACCGAAGACGACCGGGTGCTGCACAACCACAGCTTCTGCTTCGACCCCTCCGTCTGGGCGGCGTTCTGGCCGCTCGCCACGGGCGCCGCCATCGTCCTCGCCACCGAGGAGCAGATGAAGGACCCCGGCGAGATGATCACGACGCTCCGCGACCACCAGGTCACCGTGCTCGGCGGCGTGCCCTCCCTGCTGTCCCTGCTGCTCGACCACCGCGATGCGGGCACCTGCACCCGCGTCCGCCTGGTGCTCAGCGGTGGCGAACCCCTCACCGACACCCTGCTGGAGTCCGTCGAGTCGACCTGGTCCGCCGAGGTCGCCAACCTCTACGGCCCCACCGAGGCCACCATCGACGCCACCGGCCACCGCGTACCGCGCGGCGACCGCACGGTCCCGGTTCCGATCGGCCGCGCGGTGTCCAACACCGCCGTCCACGTCGTCGACGCCGAACTGCGGCCCGTACCCGAAGGCGTCCCCGGTGAGATCGTGGTCACCGGCGCGGGAGTCGCCGTCGGCTACCACGACCGGCCGGCGCTGACCGCCGCGCGCTTCCTGCCCGCGCCCTTCGCCGACGCGTCCGACGACCCGGGTGCCACCCTCTACCGAACCGGCGACCTGGGCCGCAGGCTCCCCGACGGCTCCGTCCAGTTCTTCGGCCGGGTCGACGACCAGGTCAAGATCCGCGGCCACCGCGTCGAGGTCTCCGAGGTCGAGTCGGTGCTCAAGGCCCTGGCCGGGGTCCAGGACGCGGCCGTGGTCGCCCTGGACGCGGGTACCGAGAACGCCCGGCTGGCCGCCGCCCTGGTCCTTCCGGCCGGCTCCGACGCCCCGTCCCTCGAAGACGTCCGCTCGGCACTCGCCGGCGAACTCCCCGACTACCTCGTGCCGGACCGCTTCGCCGTCGTGGACGAGCTGCCGCTCACCGCCAACGGCAAGACGGACCGCCGCGGAGTCGCCGAACTGCTCTCCCGGCAGGCAGCCGCACCGGTCGCCGGCCAGGACGGGCCCACCGAGCCCCGCAACGCCCTGGAGCGCTCCGTCGCCGAGGCCTTCGCCTCCGTGCTGCGCCTCCCCGCGATCGACATCCACGCCGACTTCTTCGACGTGGGCGGCACCTCGCTCATCCTCGCGAAGCTGGCCTCCCTGCTCGGCCGCAAGCACGATGTCGAGATCCCGCTGCACGAGTTCTTCCGTACGCCGACCGTCGCCGGCGTCTCCGAGACGATCGAGGTCTACCGCCGCGAGGGCCTCGCCGGCGTCCTCGGCCGCAAGCACGCCGCGACGCTGGAGGGCGACGGCACCCTCGACCCCTCCATCAGCCCCGAGGGCCTTCCCGAGGCGGAATGGGAGAACCCGCGGCGCGTCTTCCTCACCGGCGCCACCGGCTACCTGGGCCTCCACCTCGTCGAGCAGCTCCTGCGCCGCACCGACGCGGAGGTCGTGACCCTGTGCCGGGCCCGCGACGAACAGCACGCGCTCGAACGCCTCAAGGAGGGCTTCGCCCTCTACGAGATCGACGTCGAGGACCAGCTGCACCGGATCTCGGCCGTCATCGGCGACCTGGCCGAGCCGCGCCTGGGCCTCACCCAGGAGCAGTGGGACGACCTGGCCGCCACCGTGGACGTGATCTACCACAACGGCGCGCTCGTCAACTTCGTCTACCCGTACTCGGCGCTCAAGGCCGCCAACGTCGGCGGCACTCAGCGCGTACTGGAACTGGCCTGCACCACCCGCCTCAAGGCCGTCCACCACGTGTCCACCATCGACACCCTGCTCGCCACCCACATGCCGCGCCCCTTCCTGGAGAACGACGCGCCGCTGCACTCGGCCGTCGGCGTCCCGGCCGGCTACACCGGCAGCAAGTGGGTGGCGGAGAAGGTCGTCGACGAGGCCCGCCGCCGCGGCATCCCGGTCACCGTCTTCCGCCCCGGCCTCATCCTCGGCCACACGAAGAACGGCGCCACGCAGACCATCGACTACCTGCTGGTCGCGCTCCGCGGCTTCCTGCCCATGCGCATCCTGCCCGACTACCCCCGCATCTTCGACGTCATCCCGGTCGACTACGTGGCCTCCGCCATCGTGCACATATCCCGGAAGCGGGAAGCCATCGACGGCTTCTACCACCTGTTCAACCCCGCGCCGGTGCCGCTGCTCACCTTCTGCGACTGGATCAAGAGCTACGGCTACGAGTTCGACATCGTGCCCTTCGAGGAGGGCAGGCGCCGGGCCCTCGGAGTCGGCCCCAGCCACCTCCTGTACCCGCTCGTCCCGCTCATCAAGGACGCGGAGGCCGAGCCGCACCGGGCCCTCGACCCCAAGTACATGGACGAGGTCCAGCCCGCCCTCGAATGCGCGGAGACGCTGCGCATGCTGGCCGGCAGCGACATCGCCTGCCCGCCGACCACCGAGGCCGACGCCCACGCCGTCATGGACTACCTGGTGCGCACCGGCTTCATGCCGGCGCCCGCGGACGTCGTCCACGACGAGCCGAGCAGCACGCTGGAGGAGCGATGA	MTRHEPTETFTDTLHRVLEERGAESATPLSVEQRRLWLLGGIADGSWAVVTGRYRLQGVPDAARLQLRLASLVSRHEALRSVFVQVAERPVRLVLPFAEVALRTVNAPDSTDPARADEHVRHLVEEEFSLGHGPLLRALLLRSADGGAAELVLVGHRLVLDATSLDLLVAELLGEDAPHGREGAADTAGALETTLAAERERLADPALTQAVTGRAAELALPAATEIPGYGRRPEIKGTSYASVALPLPLALAPRAAEAADWEAAVAAAWLVVLMRSQATGSAVCGVRTARGAEQAGIVGPLDGLRLVRVDDADDAPLSDLLAAVGRQLRAPAVDVPLAHLLEVAPPRRDISRTPYAQTVVRAVDAREPLGGASGTGRQIGGAASGTEYDIEVTVRLQPGLAVAQIDYDVQLYSEERVRALGNQLAAVLDAILPGGTPEVTATVVPLLDAEGARLALEAGRGERTAPDTRSLVDLVEAQVAAAPDAVALWQGDTRVTYAQLWADATRLADELAARGVRPGDRVAVWLRRGPSTVTALLAVLAAGAAFVPVDAAYPEERVRYLLSDSRPSLVVTESSVHLLGELGLPTLLLDELSGAPAAVDGARRPDRVAADTPAYLIYTSGTTGRPKGVVVRHSSVVNNIAWRQANWQLTEDDRVLHNHSFCFDPSVWAAFWPLATGAAIVLATEEQMKDPGEMITTLRDHQVTVLGGVPSLLSLLLDHRDAGTCTRVRLVLSGGEPLTDTLLESVESTWSAEVANLYGPTEATIDATGHRVPRGDRTVPVPIGRAVSNTAVHVVDAELRPVPEGVPGEIVVTGAGVAVGYHDRPALTAARFLPAPFADASDDPGATLYRTGDLGRRLPDGSVQFFGRVDDQVKIRGHRVEVSEVESVLKALAGVQDAAVVALDAGTENARLAAALVLPAGSDAPSLEDVRSALAGELPDYLVPDRFAVVDELPLTANGKTDRRGVAELLSRQAAAPVAGQDGPTEPRNALERSVAEAFASVLRLPAIDIHADFFDVGGTSLILAKLASLLGRKHDVEIPLHEFFRTPTVAGVSETIEVYRREGLAGVLGRKHAATLEGDGTLDPSISPEGLPEAEWENPRRVFLTGATGYLGLHLVEQLLRRTDAEVVTLCRARDEQHALERLKEGFALYEIDVEDQLHRISAVIGDLAEPRLGLTQEQWDDLAATVDVIYHNGALVNFVYPYSALKAANVGGTQRVLELACTTRLKAVHHVSTIDTLLATHMPRPFLENDAPLHSAVGVPAGYTGSKWVAEKVVDEARRRGIPVTVFRPGLILGHTKNGATQTIDYLLVALRGFLPMRILPDYPRIFDVIPVDYVASAIVHISRKREAIDGFYHLFNPAPVPLLTFCDWIKSYGYEFDIVPFEEGRRRALGVGPSHLLYPLVPLIKDAEAEPHRALDPKYMDEVQPALECAETLRMLAGSDIACPPTTEADAHAVMDYLVRTGFMPAPADVVHDEPSSTLEER	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	267.09	gnl|BL_ORD_ID|4935|hsp_num:0	5928			111	1650	colistin A; colistin B
BGC0000422.1|Saframycin_31 # 37760 # 38857 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.758	BGC0000422.1|Saframycin_31 	37760	38857	+	Loose	350	25.0238	mfpA	39.29	3003035	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGACGGCACCGGCCGACACCGTCCACCCCGCCGGCCAGCCCGACTACGTGGCCCAGGTGGCCACTGTGCCCTTCCGGCTGGGACGGCCCGAGGAACTGCCCGGCACGCTCGACGAACTCCGGGCCGCCGTCTCGGCCCGGGCGGGTGAGGCCGTGCGCGGCCTCAACCGCCCGGGAGCCCGGACCGACCTGGCCGCACTGCTGGCGGCGACCGAGCGGACCCGAGCGGCCCTCGCCCCGGTCGGCGCCGGCCCGGTGGGGGACGACCCCTCGGAGTCCGAGGCCAACCGCGACAACGACCTCGCCTTCGGCATCGTGCGCACCCGCGGCCCGGTGGCCGAACTCCTCGTGGACGCCGCCCTCGCCGCGCTCGCCGGAATCCTGGAGGTCGCCGTCGACCGCGGCTCGGACCTGGAGGACGCGGCCTGGCAGCGCTTCATCGGAGGATTCGACGCGCTCCTCGGCTGGCTCGCCGACCCGCACAGCGCGCCCCGGCCGGCGACCGTACCGGGCGCAGGCCCGGCCGGGCCGCCCGTCCACCAGGACGCCCTGCGCCGCTGGGTGCGCGGACACCACGTCTTCATGGTCCTCGCCCAGGGCTGCGCGCTCGCGACGGCCTGCCTGCGCGACAGCGCGGCCCGCGGCGACCTGCCCGGGGCGGAGGCCTCGGCAGCCGCGGCCGAAGCGCTGATGCGCGGCTGCCAGGGAGCGCTGCTCTACGCCGGCGACGCCAACCGGGAGCAGTACAACGAGCAGATCCGCCCCACCCTCATGCCCCCGGTCGCACCGCCCAAGATGAGCGGCCTGCACTGGCGCGACCACGAGGTGCTGATCAAGGAGCTCGCCGGCTCCCGCGACGCCTGGGAGTGGCTCTCCGCCCAGGGCTCGGAGCGGCCCGCCACCTTCCGGGCGGCCCTCGCCGAGACGTACGACTCCCACATCGGGGTGTGCGGCCACTTCGTCGGCGACCAGTCACCCAGCCTGCTGGCCGCGCAGGGCTCGACGCGTTCCGCCGTCGGCGTCATCGGACAGTTCCGCAAGATCAGGCTGAGCGCGCTCCCCGAACAGCCCGCCACCCAGCAGGGAGAACCCTCGTGA	MTAPADTVHPAGQPDYVAQVATVPFRLGRPEELPGTLDELRAAVSARAGEAVRGLNRPGARTDLAALLAATERTRAALAPVGAGPVGDDPSESEANRDNDLAFGIVRTRGPVAELLVDAALAALAGILEVAVDRGSDLEDAAWQRFIGGFDALLGWLADPHSAPRPATVPGAGPAGPPVHQDALRRWVRGHHVFMVLAQGCALATACLRDSAARGDLPGAEASAAAAEALMRGCQGALLYAGDANREQYNEQIRPTLMPPVAPPKMSGLHWRDHEVLIKELAGSRDAWEWLSAQGSERPATFRAALAETYDSHIGVCGHFVGDQSPSLLAAQGSTRSAVGVIGQFRKIRLSALPEQPATQQGEPS	MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG	199.45	gnl|BL_ORD_ID|734|hsp_num:0	801			240	324	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000422.1|Saframycin_32 # 38854 # 41223 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.758	BGC0000422.1|Saframycin_32 	38854	41223	+	Loose	400	30.0314	Erm(36)	27.42	3000605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGAACCGCGGCTCCCGCTCCCTGCGCGAAAGCCTGGCCCGCTACGGCCCGGCCGCCGCGGCCTGCGCCGCGGCGGCCTACGCCGGCACCTCGCTCACCTCACCGCGCCCCCGCCCGGCAAGCGCTCCCCAGGAGCAGTTCTCCGCCGAGCGCGCCATGCGCCACGTCCGGGCCGTGGCCGCCGAACCCCACCCGGTCGGCTCGCGGGCCGCGGCCCGCGTCCGGGACTACCTGCTCGCCGAACTGAAGGACCTGGGCTTCGAGACGGAGGTCCAGGAGGCCGTCGCCTCCCACGACCTGGGGCCCACCCCCTACGGACCCCGGTACCTCACCGGGGGAGTGGTGCGCAACGTCATCGGCCGGCTGCCGGGCTCCATCCCCGGACATGCCGTGGCGCTGATGACGCACTACGACTCGGTGTCCCAGGGCCCGGGGGCCAGCGACGCGGGCGTACCGGTGGCAGCGCTGCTGGAAGCGGCCCGCGCACTGCGGACCGACGGCGTGCAGCCGGTCAACGACCTCCTGGTGGTGTTCACCGACGGCGAGGAAGCGGGACTGCTCGGCGCCCGGGCCTTCTTCGACCGGCACCCGCTGGCGAAGACGGTGGGCGCGGCCTTCAACTTCGAGGCCCGCGGCACCGAGGGCCCCGTCCTGATGTTCGAGGCCGGCCCGGGCAACGGCCCCATGCTGGAGGAACTGGCCCGCACCGGCGTACCCGTGTTCGCCAGCTCCCTCTTCGACGCCATCTACCGGCGCATGCCCAACGCCACCGACTTCGCCCTCGTCAAGGAGAGGGGGATCCCGGGTCTCAACTTCGCCCACATCGGAGGCTTCGCCGCCTACCATGGCCCCCTCGACGACATCGACCATGTCGAACCATCGGCCCTCCAGCACCAGGGCGAACTCGCACTGGCGCTGGCCCGCCGCCTCGGCTCCGCCGACCTGGCCGAACTCACCGGCGAGGACGCGGTCTTCTTCCCCGCCGGACGCGGAAAGCTGATCAGGGTCCCCGGCAGAGCCGTCGTCCCCCTGGCCGTCGCGGCAGGCCTGCTGGGCGCGGGCGGCCTCGGACACGCCCTGCGCAAGGGCGGCCTGACCGGCCGCCGGCTGGCCGGCACCAGCGCCCTGCTGCTCGGCCGGATCGCCGCCGGCGCGGCCGCGGGTACGGCGTTCACCGCCGCCATGGGCAAACTGGCGCCCGAGTTCCGGCGGCACGGCGACTTCCACGGCTCCGGCGACATCTACGCCGCCGTCGCCGGGCTCGCCTGCGCCGCGGTCCTCGCCGGTCCCGGCGACGCCCCGGCGGCGGCCGCCCGGACCGCCGCGGCCACACTCCCGCTGGCCGCCGCCTCTGCCGCGCTGGCCTCGGGACTGCCCGGTGGCAGCTACCTGACGACCTGGCCGCTCGCCGGCGCGGGGCTAGGACTGCGGCTGCTCGACTCCGCGCAGCCGACGGGCACCGGACGGGTTCCGTCCGTACGCCACGCGGTGGGCGCGGCCGCCGCTGCCGCCCCGGCCGCCGCCCTCCTCGTCCCGCTGTCCCGACTCCTCTTCAAGGGGCTCACCCCGCGCCTGGCCGGCACCGCCGTCGTCGCCCTCCAGCTCTGCGGCGAACTGGCCGCCCCCGCACTGGCCGGACTGCCCCGGCGCACCCGCAGGGCCGCCGCCGCGGGCGGCCTGCTGCTCGCCGGGGGCGTGGCCGCGCGGCGCTTCCTGCGGCGCGGGAAGGGTGCTCCCCCGCCGGAGACCATCAGCTACCTCCTGGACCCCGTGCACTCCACGGCACTGTGGATCAGCAGCGACGAATCGGCCTCGGAGCGGACCCGGGCCTTCCTCGGGGAACAGCCGGAGAAGGGCCGCCTGCCGGAGCACTTCCCCGGCTGGCAGCGGGACTTCCTGCACGCCCCCGCCCCCAGGCTCGACCTCCCCGCACCGGAAGTGACGGTGCTGGAGGACGGGGCCGGCGAGGCCGGCCGACGCCGGCTGCTGCTCCACCTGCGTTCACCGCGCGGCGCACGCCAGCTGTCCCTCGCCGTCGTCGGCGCAGGAGTGCGGCGGTGGCGCGTCGAGGACGGCCCGTGGTCCGAGCCGTCCCCGGCCGAGGACGACAGCTGGGAGCTGTGGCTCCACGCCGTGCCGGACCCGGGCATCCGGGTCGAACTCGAACTTCCGTCGTCCGGAACCCGGCTCCGGGTCCTCGACCGGATCGACGGACTGCCGCAGGAGCTCGCGGCGGCTCCGGGCACAGATCCCGCCACCGGGATCCCGGAGCACATCAGCCCGGCAGCCGCCCTCGACGTGGACACCTGGGGCAACGCCTCACTCGTCGTACGGACGGTGCACCTTCCGGCCCAGGAAGGGCCGGCATGA	MNRGSRSLRESLARYGPAAAACAAAAYAGTSLTSPRPRPASAPQEQFSAERAMRHVRAVAAEPHPVGSRAAARVRDYLLAELKDLGFETEVQEAVASHDLGPTPYGPRYLTGGVVRNVIGRLPGSIPGHAVALMTHYDSVSQGPGASDAGVPVAALLEAARALRTDGVQPVNDLLVVFTDGEEAGLLGARAFFDRHPLAKTVGAAFNFEARGTEGPVLMFEAGPGNGPMLEELARTGVPVFASSLFDAIYRRMPNATDFALVKERGIPGLNFAHIGGFAAYHGPLDDIDHVEPSALQHQGELALALARRLGSADLAELTGEDAVFFPAGRGKLIRVPGRAVVPLAVAAGLLGAGGLGHALRKGGLTGRRLAGTSALLLGRIAAGAAAGTAFTAAMGKLAPEFRRHGDFHGSGDIYAAVAGLACAAVLAGPGDAPAAAARTAAATLPLAAASAALASGLPGGSYLTTWPLAGAGLGLRLLDSAQPTGTGRVPSVRHAVGAAAAAAPAAALLVPLSRLLFKGLTPRLAGTAVVALQLCGELAAPALAGLPRRTRRAAAAGGLLLAGGVAARRFLRRGKGAPPPETISYLLDPVHSTALWISSDESASERTRAFLGEQPEKGRLPEHFPGWQRDFLHAPAPRLDLPAPEVTVLEDGAGEAGRRRLLLHLRSPRGARQLSLAVVGAGVRRWRVEDGPWSEPSPAEDDSWELWLHAVPDPGIRVELELPSSGTRLRVLDRIDGLPQELAAAPGTDPATGIPEHISPAAALDVDTWGNASLVVRTVHLPAQEGPA	MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR	280.78	gnl|BL_ORD_ID|818|hsp_num:0	888			93	273	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000422.1|Saframycin_34 # 41474 # 42574 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.678	BGC0000422.1|Saframycin_34 	41474	42574	+	Loose	790	25.7942	mtrC	46.88	3000810	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCATCAGCCTCGAGAACACCACCGTCGGCCAGAACCCCGCCGGTGGCCCCCCGACCGGCAAGGCCCCCCTGGACATGGAGGGTCTCGCCTGGATCCTCTTCGGCGCCTCCGCCTTCCAGTACCTCAACGCCGCGTGCGAGCTCAACCTCTTCGAGCTGCTGGAGAACAAGCCCGGTCTGACCAAGCCGCAGATCGGCGCCGAACTCGGCCTGGCCGACCGCGCCAACGACATCCTGCTGCTGGGCGCCACCGCGACCGGCATGCTCACCGTCGAGGACGGCCGCTACCAGCTCGCCACGGTCCTGGCCGAGCTCCTCAAGACGGACGACTGGCAGCGCTTCAAGGACACGGTCGGCTTCGAGCAGTACGTCTGCTACGAGGGCCAGATCGACTTCACCGAGTCGCTGCGCTCCAACAGCAACGTCGGCCTGCGCCGGGTCCGCGGCTCGGGCCGTGACCTGTACCACCGCCTGCACGAGAACCCGCAGATGGAGCAGGCCTTCTACAAGTACATGCGGTCCTGGTCGGAGCTGGCCAACCAGCACCTGGTCGAGGTCCTGGACCTGTCCGGCACCTCCAAGCTCCTCGACTGCGGCGGCGGCGACGCCGTCAACTCGATCGCGCTGGCCCAGGCCAACCCGCACATCGAGGCCGGCATCCTGGAGATCCCGCCGACTGCCCCGCTGACCGAGAAGAAGATCGCCGAGGCCGGCCTCAGCGACCGCATCACGGTCAAGCCGGGCGACATGCACACGGACGAGTTCCCCACCGGCTACGACACGGTGATGTTCGCCCACCAGCTCGTCATCTGGACCCCGGAGGAGAACACGGCGCTGCTGCGCAAGGCGTACAACGCCCTGCCCGAGGGCGGCCGGGTGATCATCTTCAACTCGATGTCCAACGACGAGGGTGACGGCCCGGTCGTGGCGGCGCTCGACAGCGTCTACTTCGCCGCGCTGCCCGCCGAGGGCGGCATGATCTACTCCTGGGCCACCTACGAGGAGTCCCTGACCAAGGCCGGCTTCAACCCCGAGACCTTCCAGCGGATCGACTTCCCGGGCTGGACCCCCCACGGCGTCATCATCGCCACCAAGTAA	MTISLENTTVGQNPAGGPPTGKAPLDMEGLAWILFGASAFQYLNAACELNLFELLENKPGLTKPQIGAELGLADRANDILLLGATATGMLTVEDGRYQLATVLAELLKTDDWQRFKDTVGFEQYVCYEGQIDFTESLRSNSNVGLRRVRGSGRDLYHRLHENPQMEQAFYKYMRSWSELANQHLVEVLDLSGTSKLLDCGGGDAVNSIALAQANPHIEAGILEIPPTAPLTEKKIAEAGLSDRITVKPGDMHTDEFPTGYDTVMFAHQLVIWTPEENTALLRKAYNALPEGGRVIIFNSMSNDEGDGPVVAALDSVYFAALPAEGGMIYSWATYEESLTKAGFNPETFQRIDFPGWTPHGVIIATK	MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK	88.83	gnl|BL_ORD_ID|1232|hsp_num:0	1340			333	429	erythromycin; penicillin; azithromycin
BGC0000422.1|Saframycin_35 # 42666 # 43202 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.715	BGC0000422.1|Saframycin_35 	42666	43202	+	Loose	400	38.891	vanR gene in vanA cluster	25.88	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCTGACCACTCCGGACGAAGACAAGGTGAGGATCGTCCGCTGGCCGCTGGAAACGGCCAAGCGGGAGCGATGCAGGGAAGCCGGAGCCCTGCGGATCCTCCTCGTCGAGAACGGCGCGAAGCCACCGCTGACGGCCGACCTCCGGGAGGACTGGGTCAGGGCCCCCGTCAGCAGGGAAGACCTCGCGGCCCGGGTCACGGCCCTGCGCGCCAAAGCCGGTGCCTATCGGGTCCCCACCCTCGACGTGGACGGCGAGCTGCGCTTCGACGGCCGCTCGGTCGTGCTCTCCCGCGCGGAGGTCGCCATCGTCTCCGTACTCGTGCGCAATTACGGCTCCCTGGTCGCCAGGGAGTCGCTCGCGCACCTGCCGGACGCTCCCCGAGCGGGCAGCCGCAACGCGCTCGACCTGCACGTGATGCGCATCCGCCGGCGCATCGCCCCGCTGGGCCTGGGCATCAGCACGGCCTGGGGCCGCGGCTACCTGCTCCAGGAGCTGACGCAGGAAGCGCAGGGACAGGACGCGGGAGGAACCTAG	MLTTPDEDKVRIVRWPLETAKRERCREAGALRILLVENGAKPPLTADLREDWVRAPVSREDLAARVTALRAKAGAYRVPTLDVDGELRFDGRSVVLSRAEVAIVSVLVRNYGSLVARESLAHLPDAPRAGSRNALDLHVMRIRRRIAPLGLGISTAWGRGYLLQELTQEAQGQDAGGT	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	77.06	gnl|BL_ORD_ID|750|hsp_num:0	722			438	693	vancomycin; teicoplanin
BGC0000422.1|Saframycin_36 # 43343 # 44533 # -1 # ID=1_36;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000422.1|Saframycin_36 	43343	44533	-	Loose	200	27.7202	vanH gene in vanO cluster	30.59	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGGAACGGACGGACCACCAGGTGACCTCCATCGGAAACACCGAAGACGCCGGTTCGCTGATCAGCGTCACCGTGATCGGCACCGGCCTGATCGGAACCTCCATCGGCCTGGCACTCACCGAGTACGGTGTCCGGGTCCACCTCCAGGACGTCCATGCGGAATCGGTGCGGATCGCCGAGGCCAGGGGGGCGGGCACCGCGCTCGCCCCCGAGCGCCAGACGGACCTGGCGGTCATCGCCGTGCCTCCGCAGAGCGTGCGAACGGCTCTCGCTGACGCCCAGCGACGGCGGATCGCCCGCCACTACACCGACGTGGCCAGCGTCAAGGCGGCGCTCCCCGCGGCGGGGGCGGACCTCGGCTGGGACGCCTCCCGGTTCATCGGGGGACATCCCATCGCCGGCCGGGAACACCCGGGGCCCGGCGCGGCCCGCAGCGACATGTTCAGGGCCAAGCCGTGGATCCTCACCCCCAGCGCTGACACCTCGCAGGAGACGATCGCCACGGCCCGCCGGCTGATCGGCCTGTGCGGGGCGGACGTGGTGACGATGCAGCCGGAGGCACACGACCGGGCCGTCGCCATGACCTCCCACCTGCCGCACCTCGTCAGCAGTCTGATGGCCCGCCTGCTGCGGTCCTACGACCACCGGGCGCTGGAGCTGTCCGGCTCCGGGCTGCGTGACTTCACCAGGATCGCGGCCGGCGACCCCGACCTGTGGACCGACATCCTCGGATCCAACGCCACCGCGGTGCTCGGCGCCCTGGAAAACCTGCAGCACGACCTGGAGATGACCCGTCGTATCCTGCACGCGCTCGCCGCTTCCCCGGGGGCCGCCGAGGCCGCCGAGGCCCCGGCCTACCGCGAGCTGCTCCGCCGGCTCCTGGAGGAGGGCCGGGCGGGACAGCTGCTGATCCCGCAGAAGTACGGGGCGGCAGGACGCGCGTACGACAAGCTCCAGGTGCTCCTCACGGACCGCGAGGGGGAACTGGCCCGGCTGTTGGCGGATGTGAGCGAGTTGAACGTGAACGTCGAGGATCTGTGGATCGAGGACTCCGCGGATTCCCCCGTCGGCCTCGCCGTCCTCTCGGTCGACGCCGGCATGGCGTCCATGCTGTCGGACTGGCTGGCGGAGCGCGGCTGGCCGGTGCTGGGGGAGTCCATGTCAGCGGATCCGGTGGCCGGGAGGGTGTGA	MERTDHQVTSIGNTEDAGSLISVTVIGTGLIGTSIGLALTEYGVRVHLQDVHAESVRIAEARGAGTALAPERQTDLAVIAVPPQSVRTALADAQRRRIARHYTDVASVKAALPAAGADLGWDASRFIGGHPIAGREHPGPGAARSDMFRAKPWILTPSADTSQETIATARRLIGLCGADVVTMQPEAHDRAVAMTSHLPHLVSSLMARLLRSYDHRALELSGSGLRDFTRIAAGDPDLWTDILGSNATAVLGALENLQHDLEMTRRILHALAASPGAAEAAEAPAYRELLRRLLEEGRAGQLLIPQKYGAAGRAYDKLQVLLTDREGELARLLADVSELNVNVEDLWIEDSADSPVGLAVLSVDAGMASMLSDWLAERGWPVLGESMSADPVAGRV	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	113.14	gnl|BL_ORD_ID|761|hsp_num:0	786			525	753	vancomycin
BGC0000422.1|Saframycin_37 # 44539 # 45993 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.675	BGC0000422.1|Saframycin_37 	44539	45993	-	Loose	900	30.0314	AAC(6')-Ie-APH(2'')-Ia bifunctional protein	35.29	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	ATGACGAACCTGTCCCCCGCCGATTTCAAGGTCGCCGACCTTTCCCTTGCCGCCTTCGGCCGCAAGGAGATCACCCTGGCCGAGCACGAGATGCCGGGCCTGATGTCGATCCGCAAGGAGTACGCCGCGGCGCAGCCGCTGGCCGGCGCCCGTATCACCGGCTCCCTGCACATGACGGTCCAGACGGCCGTCCTCATCGAGACCCTCGTCGCGCTCGGCGCGGATGTCCGCTGGGCCTCCTGCAACATCTTCTCCACCCAGGACCACGCCGCGGCCGCCATCGCGGTCGGCCCGGACGGCACCCCGGAGAACCCGCAGGGCGTCCCCGTCTTCGCCTGGAAGGGGGAGACGCTGGAGGAGTACTGGTGGTGCACGGAGCAGGCGCTGACCTGGCCGAACACCCCCACCGGCGGCCCGAACATGATCCTCGACGACGGTGGTGACGCCACCCTCCTCGTCCACAAGGGCGTCGAGTTCGAGAAGGCGGGCGCGGCCCCGGACCCGTCCACCGCGGACTCCGAGGAGTACGGCCACATCCTCACGCTGCTCAACCGCACCCTCGGCGAGACCCCGCAGAAGTGGACGCAGCTCGCGTCCGAGATCCGCGGTGTGACGGAGGAGACCACCACCGGTGTCCACCGTCTCTACGAGATGATGGCCGAGGGCACCCTGCTGTTCCCGGCGATCAACGTGAACGACGCCGTGACGAAGTCGAAGTTCGACAACAAGTACGGCTGCCGCCACTCCCTGATCGACGGCATCAACCGCGCCACCGACGTGCTGATCGGCGGCAAGGTCGCGGTCGTGTGCGGTTACGGCGACGTCGGCAAGGGCTGCGCGGAGTCGCTGCGCGGGCAGGGCGCGCGGGTCATCGTCACGGAGATCGACCCGATCTGCGCGCTGCAGGCGGCGATGGACGGCTACCAGGTCGCCACGCTGGACGACGTGGTGGAGATCGCGGACATCTTCATCACCACGACCGGCAACAAGGACATCATCATGGCCTCGGACATGGCCAAGATGAAGCACCAGGCGATCGTGGGCAACATCGGCCACTTCGACAACGAGATCGACATGGCCGGCCTGGCAAAGATCGAGGGCATCGTCAAGGACGAGGTCAAGCCGCAGGTCCACACCTGGAAGTTCCCCGACGGCAAGGTCCTGATCGTGCTCTCCGAGGGCCGCCTGCTCAACCTGGGCAACGCGACCGGCCACCCCTCGTTCGTGATGTCGAACTCCTTCGCGGACCAGACCCTGGCCCAGATCGAGCTCTTCACCAAGCCGTCCGAGTACCCGACCGACGTCTACGTGCTCCCCAAGCACCTCGACGAGAAGGTCGCCCGCCTCCACCTCGACGCGCTCGGCGTCAAGCTCACCACCCTGCGCCCGGAGCAGGCCGCCTACATCGGCGTCCAGGTCGAGGGCCCCTACAAGCCCGACCACTACCGCTACTGA	MTNLSPADFKVADLSLAAFGRKEITLAEHEMPGLMSIRKEYAAAQPLAGARITGSLHMTVQTAVLIETLVALGADVRWASCNIFSTQDHAAAAIAVGPDGTPENPQGVPVFAWKGETLEEYWWCTEQALTWPNTPTGGPNMILDDGGDATLLVHKGVEFEKAGAAPDPSTADSEEYGHILTLLNRTLGETPQKWTQLASEIRGVTEETTTGVHRLYEMMAEGTLLFPAINVNDAVTKSKFDNKYGCRHSLIDGINRATDVLIGGKVAVVCGYGDVGKGCAESLRGQGARVIVTEIDPICALQAAMDGYQVATLDDVVEIADIFITTTGNKDIIMASDMAKMKHQAIVGNIGHFDNEIDMAGLAKIEGIVKDEVKPQVHTWKFPDGKVLIVLSEGRLLNLGNATGHPSFVMSNSFADQTLAQIELFTKPSEYPTDVYVLPKHLDEKVARLHLDALGVKLTTLRPEQAAYIGVQVEGPYKPDHYRY	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	101.04	gnl|BL_ORD_ID|4823|hsp_num:0	1814			1116	1218	dibekacin; amikacin; sisomicin; netilmicin; kanamycin A; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000422.1|Saframycin_38 # 46023 # 46964 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.703	BGC0000422.1|Saframycin_38 	46023	46964	-	Loose	500	27.7202	BJP-1	27.12	3000856	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BJP beta-lactamase	ATGGCAGCAGAGACCGCGGAGTTCCCGTACCGCGCCCGTCCGGGCCGCCTGGGGGACCTGCTCCGCACGGGGCAGAAGTCGTATTCGTTCGAGTTCTTCCCTCCGAAGACGGCAGCCGGCGAGCGGACGCTGTGGAGGGCGATCCGCCGCATCGAGGCCTTCTCACCGTCGTTCGTCTCCGTCACGTACGGGGCCGGAGGTTCCTCCCGGGACCGGACGGTCGAGGTGACCAAGCGGATCGCGGCGGACACCACGCTGCGCCCGGTCGCGCACCTGACCGCCGTCGGCCACTCGATCGCCCAACTACGCCACATCATCGGCCAGTACGCCGACGCCGGCATCCGGGATGTCCTGGCTCTGCGGGGCGACCCGCCGGGCGATCCCAAGGGCGAGTGGGTCCCCCATCCCGACGGGCTCCGTCATGCCGCTGAACTCGTTTCCCTCACGAGGGAACTGGGAGATTTCACGGTTGGCGTGGCGGCCTTTCCCGAGCGGCATCCACGCTCGCCGGACTGGGACAGCGACATCCGTCACTTCGTCGCCAAGTGCCGGGCCGGCGCCGACTACGCCATCACCCAGATGTTCTTCCGCGTCGACGACTACCTCCGGCTGCGCGACAGGGTCGCGGTCGTCGGCTGCAACACGCCGATCATCCCCGCGATCATGCCCGCCACCGACGTACGCCAGATCCGCCGCTTCGCGGAACTCAGCAACGCGTCGTTCCCCGACGAACTCGCCCGACGGCTCGACGCCGCCCGCGACGACCCCTCCGAGGGCCACCGCATCGGCGTCGACCACGCCACCGCCATGGCCGACCGCCTCTTGGCCGAAGGTGCGCCCGGCCTGCACTACATCACCCTCAACCGGTCCACCGCGACCGTCGAGATCCATCGGAACCTCGGTCTGTCGCCTGCCCGGCAGCCCGCCGCAGCCCGCCACTGA	MAAETAEFPYRARPGRLGDLLRTGQKSYSFEFFPPKTAAGERTLWRAIRRIEAFSPSFVSVTYGAGGSSRDRTVEVTKRIAADTTLRPVAHLTAVGHSIAQLRHIIGQYADAGIRDVLALRGDPPGDPKGEWVPHPDGLRHAAELVSLTRELGDFTVGVAAFPERHPRSPDWDSDIRHFVAKCRAGADYAITQMFFRVDDYLRLRDRVAVVGCNTPIIPAIMPATDVRQIRRFAELSNASFPDELARRLDAARDDPSEGHRIGVDHATAMADRLLAEGAPGLHYITLNRSTATVEIHRNLGLSPARQPAAARH	MRRLTAALCALTLLSTGAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVIKTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKLILNTHAHLDHTGGFAEIKKETGAQLVAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRAVKEGDRVTLGDTTLTAHATPGHSPGCTSWEMTVKDGKEDREVLFFCSGTVALNRLVGQPTYAGIVDDYRATFAKAKAMKIDVLLGPHPEVYGMQAKRAEMKDGAPNPFIKPGELVTYATSLSEDFDKQLAKQTAALEKK	106.46	gnl|BL_ORD_ID|1936|hsp_num:0	1942			231	567	
BGC0000422.1|Saframycin_40 # 50479 # 51462 # -1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	BGC0000422.1|Saframycin_40 	50479	51462	-	Loose	1020	26.5646	tlrC	65.22	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGCGCATCGCGATCACCGGATCCATCGCCACCGACCATCTGACGACCTTCCCCGGCCGTTTCGCCGAGCAGCTGATACCCGACCGGCTGGACACGATCTCGTTGTCCTTCCTGGTGGACGACCTGGAGGTGCGCCGCGGCGGCGTCGCGGCGAACATCGCATTCGGCCTGGGACGTCTGGGATTCTCCCCGTTGCTGGTCGGCGCCGCCGGCACCGACTTCCCCGAGTACGACTCCTGGCTTCGCGAACACGGCGTCGACACCGGCTCCGTGAGGGTGAGCGCCACACGGCACACGGCCCGTTTCATGTGCACCACGGACGCGGACCAGAACCAGATCGCCTCCTTCTACACCGGTGCCATGGTCGAGGCCCGCGAGATCGACCTGGCCGATGTGGTGCGCCGTTCGGGACCGCTGGACCGGGTCGTTGTCGCGCCGGACGACCCCGAGGCGATGCTGCGGCACTCGGCGAAGACCCGTGAACTGGGCATTCCCCTCGCTGCGGATCCGTCGCAGCAGCTCGCGCGGCTGAATGGCGACGAGACCCGGCGTCTGGTGGACGGCGCCGAGTTGCTGTTCACCAATGAGTACGAGGCCGCCCTGCTCCAGGAGTGCACCGGATGGACCGCACACCAGGTCCTCCAGCGGGTGGGCACCTGGATCATCACCTGCGGCGGTGACGGCGTCACGATCCACAACACCGACACCCCGTCCGTCAGCGTGCCGGCCGTCCCCGCCAAGAACGTCGCCGACCCGACGGGCGTCGGCGACGGGTTCCGCGCCGGGTACCTGGCGGGGATCGGCCAGGGGCTGTCGCAGGAGCGCGCAGCCCAGCTGGGCTGCGCGCTGGCCACAACCGTCCTGGAGTCGGTAGGCACGCAGGAATACCGGCTGGACCGGTCGTCCCTCACGGCCCGGATCGCGGACGCGTACGGTGACGGACCGGCCGCCGAGATCACGCCCCACCTCCAGGCCAAGCCGTGA	MRIAITGSIATDHLTTFPGRFAEQLIPDRLDTISLSFLVDDLEVRRGGVAANIAFGLGRLGFSPLLVGAAGTDFPEYDSWLREHGVDTGSVRVSATRHTARFMCTTDADQNQIASFYTGAMVEAREIDLADVVRRSGPLDRVVVAPDDPEAMLRHSAKTRELGIPLAADPSQQLARLNGDETRRLVDGAELLFTNEYEAALLQECTGWTAHQVLQRVGTWIITCGGDGVTIHNTDTPSVSVPAVPAKNVADPTGVGDGFRAGYLAGIGQGLSQERAAQLGCALATTVLESVGTQEYRLDRSSLTARIADAYGDGPAAEITPHLQAKP	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	59.67	gnl|BL_ORD_ID|1841|hsp_num:0	1997			1014	1083	lincomycin; tylosin; mycinamicin
BGC0000422.1|Saframycin_41 # 51464 # 52669 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.693	BGC0000422.1|Saframycin_41 	51464	52669	-	Loose	1500	26.9498	rphA	35.42	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGGGCCGTCTCTTCACGTCTGAATCGGTGACCGAAGGTCACCCCGACAAGATCGCCGACCGGATCAGCGACACCATCCTCGACGCCCTGCTGCGCGAGGACCCGAGCAGCAGGGTCGCGGTCGAGACCCTGATCACCACCGGCCAGGTGCATGTCGCCGGCGAGGTGACGACGAAGGCGTACGCGCCGATAGCGCAGCTCGTCCGCGACGCGATTCTCGACATCGGCTACGACTCCTCCGCCAAGGGCTTCGACGGCGCTTCCTGTGGCGTGTCGATCTCGATCGGTGCGCAGTCGCCCGACATCGCCCAGGGCGTGGACACCGCCTACGAGCAGCGCGTCGAGGGCGAGGGCGACGAGCTGGACAAGCAGGGCGCCGGCGACCAGGGCCTGATGTTCGGGTACGCCTGCGACGAGACGCCCGAGCTGATGCCGCTGCCGATCCACCTCGCCCACCGGCTCTCCCGCCGGCTGTCCGAGGTCCGCAAGGACGGCACCATCCCCTACCTGCGTCCCGACGGCAAGACGCAGGTCACGATCGAGTACGACGGTGACAGGGCTGTGCGCCTCGACACCGTCGTCGTCTCCACCCAGCACGCCGCGGACGTCGACCTGGACGCCCTCCTCACCCTCGACGTCCGCGAGCACGTGGTCGAGCACGTCCTGAAGCAGCTCGTCCAGGAGGGGATCAAGCTCGACACCGACGGCTACCGGCTGCTGGTGAACCCGACCGGCCGATTCGAGATCGGCGGCCCGATGGGCGACGCGGGTCTGACCGGCCGCAAGATCATCATCGACACGTACGGCGGGATGGCCCGTCACGGTGGTGGCGCGTTCTCCGGCAAGGACCCGTCCAAGGTCGACCGTTCGGCCGCGTACGCGATGCGCTGGGTCGCGAAGAACGTGGTCGCCGCCGGGCTCGCCTCGCGCTGCGAGGTGCAGGTCGCGTACGCGATCGGCAAGGCCGAGCCCGTCGGCCTGTTCGTGGAGACCTTCGGCACCGCCAAGGTCGACACCTCGAAGATCGAAGAGGCCATCGGTCAGGTCTTCGACCTGCGCCCCGCCGCCATCATCCGCGACCTGGACCTGCTGCGGCCCATCTACGCGCAGACCGCCGCGTACGGCCACTTCGGCCGCGAGCTGACCGACTTCACGTGGGAACGCACCGACCGCGCCGACGCCCTGCGCAGGGTCGCGGGGGTCTGA	MGRLFTSESVTEGHPDKIADRISDTILDALLREDPSSRVAVETLITTGQVHVAGEVTTKAYAPIAQLVRDAILDIGYDSSAKGFDGASCGVSISIGAQSPDIAQGVDTAYEQRVEGEGDELDKQGAGDQGLMFGYACDETPELMPLPIHLAHRLSRRLSEVRKDGTIPYLRPDGKTQVTIEYDGDRAVRLDTVVVSTQHAADVDLDALLTLDVREHVVEHVLKQLVQEGIKLDTDGYRLLVNPTGRFEIGGPMGDAGLTGRKIIIDTYGGMARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLASRCEVQVAYAIGKAEPVGLFVETFGTAKVDTSKIEEAIGQVFDLRPAAIIRDLDLLRPIYAQTAAYGHFGRELTDFTWERTDRADALRRVAGV	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	46.36	gnl|BL_ORD_ID|890|hsp_num:0	910			1089	1218	rifampin; rifaximin; rifabutin; rifapentine
BGC0000422.1|Saframycin_42 # 52690 # 53736 # -1 # ID=1_42;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.681	BGC0000422.1|Saframycin_42 	52690	53736	-	Loose	500	31.9574	chrB	29.58	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGTACGAGTTGAGCGCGGAACAGCGGGAGGCGGCTGCCGTCATGAGACGGATGCTGTATGCCCAGCTTCCTTCTCGTGCGCTGGTCGTCGTCGCGCAGTTGGGGATCGCGGACATCCTCGCGGAGGGGCCTGCGGACATCTCGACCCTCGCGGAGCGGACCAGCACGGACGCCGTGGCACTCGCCCGCCTGCTGCGTGGTCTCGCCGTGTTCGGCGTGTTCGAGGAGGGCGCCGAACAGGTCTACTCGCTGACTCCGCTCGGTGAGGCCCTCACCTCCGGGCACCCGGCTTCCGCACTTCCGTCGGCCACGCTGGTGGCAGGGCAGTTCGGTGCCGCCTGGGGCGACTTGCTGGAGACCGTGCGGACGGGACAGTCGCCGTTCGAGCGCAGCCGAGGCGTCTCGCTCTTCACCCACATGGAGCAGGACGAGGAGCTTCGCGCGGTCTTCGACGACTCCCAGGGCCGCGGACTGGCTCTGGAGCTGGACGAGATCCTGCGCGCGATCGACTTTTCCGCTTATCCCACGGTCGTGGACGTAGGCGGCAGCGACGGAACGTTTCTTCGCCGGATCCTGTCAGCACATCCCGACATCAGCGGCATCGTCTTCGATCTGCCCGGCTCGACGTCCCTCCAGGCGGAGCGCCCCACCGCGGATCCGCTGGAGGGCCGCTACTCCGTGGCCACGGGGGACTTCTTCGACAGCCTCCCCGAGGGGGGCGACCTCTATCTGCTCTCGCACATCCTGCATGACTGGGACGACGATCGAGCGGTGCAGATCCTGCGCACCTGTCGCGCCGCCATGTCCGACGACGCGACGCTGATGGTCGTCGACCTGATCGCCGCGAACCGCGGACAGCGGGACGAGCGGCTGCACACCGCGGCCCTGATGGACCTCTACATGCTCTCCCTGTTCGGCGGCAACGGCGGCCAGGAACGGACTGCGGCGCAGGTCGAAGTCCTGCTGAGCAAGGCCGGGTTCCGCATTACCCGTGTGGACTCCCTGCCCAGTGGCATGAACGTCATTCGTGCGGTCCGCGCCGCCTGA	MYELSAEQREAAAVMRRMLYAQLPSRALVVVAQLGIADILAEGPADISTLAERTSTDAVALARLLRGLAVFGVFEEGAEQVYSLTPLGEALTSGHPASALPSATLVAGQFGAAWGDLLETVRTGQSPFERSRGVSLFTHMEQDEELRAVFDDSQGRGLALELDEILRAIDFSAYPTVVDVGGSDGTFLRRILSAHPDISGIVFDLPGSTSLQAERPTADPLEGRYSVATGDFFDSLPEGGDLYLLSHILHDWDDDRAVQILRTCRAAMSDDATLMVVDLIAANRGQRDERLHTAALMDLYMLSLFGGNGGQERTAAQVEVLLSKAGFRITRVDSLPSGMNVIRAVRAA	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	124.29	gnl|BL_ORD_ID|274|hsp_num:0	305			246	444	tylosin; chalcomycin; mycinamicin
BGC0000422.1|Saframycin_43 # 54002 # 55132 # 1 # ID=1_43;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.721	BGC0000422.1|Saframycin_43 	54002	55132	+	Loose	900	46.595	iri	30.77	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGACGGAGAACCCGCGACGCCCGCCCCTGGTGGTGGGGGCGAGCGCCGCGGGCCTGACGGTCGCCCACGAACTGGCCCGGCGTGGACTGCCCGTGCGCGTCATCGAAGCCTCAGCCGGACCGGCCACGACAGGGCCCGCGGTGACACTCCAGCCGCGTACCCTGGAAGTGCTCGACCAGATGGCGGTCATCGACGGCTTCCTCCGCCACGGACGCAAGGGCGAGACCCTCGCCGACCACACGACGCTGCCCACCCTTCACCCGTACACGCTCGTCATCGACCGGGCCCGGGCCGCGGCCCTGCTCCGCGAAGCCGTCGTCGACCTCGGCGTAAGCGTCGAGGGGGGCGCGCGGGACCGGCACCCTGCCGCCCCGGCTTGTCTGATCACCTGCGACGGCTTCCCGCAGCGCTCGGATCCGGTCGGCCGCCGCCTCACCGTCGTGGCGGACCACGACCCCGACACCGGGATCCGGCAGGCTTACAACCTCGCCTGGAAACTGGCGATGGTCGAGCAGGGCCTCGTGGGTCCGCGCTTGCTGGACACCTACGACGAGGAGCATCCTGCGGAGCGAGGCCACCGGCCGGGGATCCGTGCACTCCTCAACGCTGTCCCCGCTCTCCGGCGCACTCATCCAAGCCACCGCTCAGGGCTGGGGCTCACCTACCGGAACAGCTCCCTGACCACGCGGAACACCCTCGACTTCCTCTCCGGTTACCACGTCGGCGCGGTGGGATTCGAACCGACTCCCGTCCCCGCGCCCGGTTCCCGCGTCACTGAGGCCGGGCCGGCCTGCAACCTGCTGCGCTCCGAGCTGAGGGACCCACGATGGTCCCTGCTGTTCGCGACGGACCCAGCCGGCACCCAGGGCTCACCGGACTCCGTGGCCGCCACCGCCGCTGCCCAGTACAGCGCCTACTTGTCGGTCCGCATCCTGGGAGCCGCTTCCCTCCCCGACCCCCTCTGCCGACTGCGCGCCGCGCTGGGCACGCCTCCGGGCGGCTGGCTCCTGATCCGGCCGGACGGCTACGTGGCTGCACGCGGCAGCCTCCTGACCAGCCAAGCCCTCGACCGGGCACTGTCCCCGCTCTCCGTCGCCCCTCTAAGAATCGGAGCCAACCCATGTGGCTGA	MTENPRRPPLVVGASAAGLTVAHELARRGLPVRVIEASAGPATTGPAVTLQPRTLEVLDQMAVIDGFLRHGRKGETLADHTTLPTLHPYTLVIDRARAAALLREAVVDLGVSVEGGARDRHPAAPACLITCDGFPQRSDPVGRRLTVVADHDPDTGIRQAYNLAWKLAMVEQGLVGPRLLDTYDEEHPAERGHRPGIRALLNAVPALRRTHPSHRSGLGLTYRNSSLTTRNTLDFLSGYHVGAVGFEPTPVPAPGSRVTEAGPACNLLRSELRDPRWSLLFATDPAGTQGSPDSVAATAAAQYSAYLSVRILGAASLPDPLCRLRAALGTPPGGWLLIRPDGYVAARGSLLTSQALDRALSPLSVAPLRIGANPCG	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	78.50	gnl|BL_ORD_ID|729|hsp_num:0	796			12	363	rifampin; rifaximin; rifabutin; rifapentine
BGC0000422.1|Saframycin_44 # 55123 # 55248 # 1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.706	BGC0000422.1|Saframycin_44 	55123	55248	+	Loose	900	21.557	lmrB	46.67	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTGGCTGATGTGGTTCTTCCGCCGTCTCGTGACAACCTCCGCGGACGTACGCCCCTACCATCACGAGCAGCCCCGGCACCGCCGCCGCCACCTGCGGCGGGCCACTGCCGGCCGACGCGACTGA	MWLMWFFRRLVTTSADVRPYHHEQPRHRRRHLRRATAGRRD	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	8.60	gnl|BL_ORD_ID|540|hsp_num:0	592			1041	1086	
BGC0000422.1|Saframycin_45 # 55498 # 55959 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.665	BGC0000422.1|Saframycin_45 	55498	55959	+	Loose	600	23.8682	BCL-1	33.33	3004749	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BCL Beta-lactamase	ATGCACAGTCGATGCCCTGCCACCAGACTCAGCGCCACGGTCACACCGATCGGCACCACGACGTCGAGCGTGCTGGACGCCCATGCCCAAGCCGCCCGCGACGGCCTGCGGGAGAAGCAGTCCCCGCACTATGTGATTCTGACGCTCTCCGGTGACGGGTCGTCGATCTCAGTGGAGCAACAGGGACCGGGAGACCGCTACGAGTTCCTCGACAAACTGGCCGGGAGGAGCTGCCGCTACGGCCTGTGTACCGTGCCCTCCAAGATGGGCGAAACACAAGTCGTCTTCGTCCGCTGGACCCCTGTGGACGCGCCCGCCGAAGAAAAGACGCTCTATGACTCCTACGAGGAGAGCGCCCGGCAAGCGCTCACTGCTCCCCAGGACGTGGCTCCGCGCACCGACCGCTCCGAACCGCAGGACCTTCGCGGGCGCCGAACACCTGAGGCAACCCGAGGGCGGTGA	MHSRCPATRLSATVTPIGTTTSSVLDAHAQAARDGLREKQSPHYVILTLSGDGSSISVEQQGPGDRYEFLDKLAGRSCRYGLCTVPSKMGETQVVFVRWTPVDAPAEEKTLYDSYEESARQALTAPQDVAPRTDRSEPQDLRGRRTPEATRGR	MKRSFFMLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAARLGVFALDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNYNPITENHVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERIEPELNHVEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGVPEGWEVGDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVINLLAQTE	49.84	gnl|BL_ORD_ID|2374|hsp_num:0	3559			519	600	
BGC0000422.1|Saframycin_46 # 55865 # 56437 # -1 # ID=1_46;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000422.1|Saframycin_46 	55865	56437	-	Loose	770	25.0238	Klebsiella pneumoniae acrA	35.48	3004041	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCACTGCTCACCGACGACGCGACCGCGATCTCCGACGGAGCCGGCCTGACCGAGAAGCTGCTGCGGTGCGACACTCCTCAGCGCATCGCCGCCATCGCACGGGCCGGCTTCAGGTCAACTCCCGCGAAGCAGCGGCTCGGCGGCGTCTCCGCTGTCCACTACGCACTCGCCATTCTTTTCGTGCCCGACGGCAGGGTCGTCGGCGCCGTGACGTTCGACATCTCGGACGGCAAGCTCGCGACCGTGCGGGGCATCGCCACCCCCGCTCGCGTCGTCCGCCTCACCAAAGCCTGGCGGCAGCATGAACCGACACGCCGCTCATCACCCAGTGGGCGGTGCCCGGTCGGGCTCGGGGGCTCCGTCGCGCACCGGCATCCCCTTGTGGTTCGGGGCGAAGGCATGGTCCAGGTGGTCGGGTGGCCGGGCGAGACCTCACGCTCAGACGGGCCGTGTGGCGGTCAGGGTCCTGGGCCTTTCACCGCCCTCGGGTTGCCTCAGGTGTTCGGCGCCCGCGAAGGTCCTGCGGTTCGGAGCGGTCGGTGCGCGGAGCCACGTCCTGGGGAGCAGTGA	MALLTDDATAISDGAGLTEKLLRCDTPQRIAAIARAGFRSTPAKQRLGGVSAVHYALAILFVPDGRVVGAVTFDISDGKLATVRGIATPARVVRLTKAWRQHEPTRRSSPSGRCPVGLGGSVAHRHPLVVRGEGMVQVVGWPGETSRSDGPCGGQGPGPFTALGLPQVFGAREGPAVRSGRCAEPRPGEQ	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVFLYQIDPATYQGSYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTQYISQQDYDPAVATAQQNNAAVVAAKTAVETARINLAYTQKSPLRSAAGSGKSPVTEGALVQNGQTTALATVQQVDPIYVDVTQSSNDFLRLKQELADARLKQENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	47.74	gnl|BL_ORD_ID|2319|hsp_num:0	2659			501	594	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000422.1|Saframycin_47 # 56920 # 57099 # 1 # ID=1_47;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.667	BGC0000422.1|Saframycin_47 	56920	57099	+	Loose	575	21.9422	ELM-1	44.44	3006885	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ELM beta-lactamase	GTGCGCAGTTCTTCGTTCTCGCAGGCGCGGATCCGGTGGGCCGAGGCCGTGGACGAGGTCCAGAAGGCCATTGTGACGTGGGCGAAGGACAGCGGACAGCGCCGAATCGACATCGAGGACCGGCTCACGGGCGAGGTTCAGGGCGGTAAGGCTCCCCAGCTCTGGCCGAAAGCCGGATAG	MRSSSFSQARIRWAEAVDEVQKAIVTWAKDSGQRRIDIEDRLTGEVQGGKAPQLWPKAG	MPMEQALFVRIARALAASLITLSAVAFAQEPKVDIPADQQAFVDICKPWDEWDKPAPPFEIYRDTYYVGTCGIAAILITDEEGHILIDSGTEAGADVVMANVAALGFDLKDVRYLLYSHEHFDHVGGMAKLQRATGALVVASKAAEPVLTSGEDSLADPQHGMHEPFEGVAVGRIMAAGDILELGGTTIRAIETPGHTPGAMSWWWQECKERCENIVYADSLSPISRDDYRFGDHPEYVAAYRAGLVALGREDCTVLLTPHPSHSRMIRRMQEGDLIENRQGTRPCARYAGQKLLDLETRLSNETLSEEDRAQ	18.85	gnl|BL_ORD_ID|3530|hsp_num:0	4599			858	912	
BGC0000422.1|Saframycin_48 # 57211 # 57681 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.743	BGC0000422.1|Saframycin_48 	57211	57681	+	Loose	400	23.483	ErmN	32.5	3000592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGTGCTGCGGCCGCTGGTTGAGCCGATGCTCGCGCTGGCCGCCGAGGTGTTCCCGGGCCCGGCGGTGCTGCGGGCCGGGGTGGCGTATGAGCAGAAGTTCGACGGTCGTCGCGAGTTCTTGTTCACGGCGTCCGGGCCGGGTGGGCGGGTGCTGCTCCAGACTCGGCGCGGGTCCCTGGTCCAGGACCGGTGGCCGGACCTGGTGGCGGCCGCCGAGGCACAGCTCCCCGCCGGGCTGGTCCTGGATGGCGAACTGCTCGTCTGGGCCGTCGAGGCCGGGCGGTTGTCGTTCGAGGGGTTGCAGCGCCGGGCCGCCGCCCGCGCCCGCGGTGCGCCCGCCCTCGCCGCGTCCTTGCCGGCGTACTTTGTGGCGTTCGATGTCTTGCAGCTCGACGGCCGGGAGCTGCTGGCCCGCCCCTACTCGAGCGCCGCGCCCGCCTTGAGGGCCTGTTCGCGGAGTACGGGCTGA	MVLRPLVEPMLALAAEVFPGPAVLRAGVAYEQKFDGRREFLFTASGPGGRVLLQTRRGSLVQDRWPDLVAAAEAQLPAGLVLDGELLVWAVEAGRLSFEGLQRRAAARARGAPALAASLPAYFVAFDVLQLDGRELLARPYSSAAPALRACSRSTG	MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSVTVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPLRFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTFRRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAARALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR	53.61	gnl|BL_ORD_ID|232|hsp_num:0	260			258	372	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
